BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209-218. [PMID: 20890893 DOI: 10.1002/hep.23922] [Cited by in Crossref: 546] [Cited by in F6Publishing: 554] [Article Influence: 49.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
2 Matthaei M, Hu J, Kallay L, Eberhart CG, Cursiefen C, Qian J, Lackner EM, Jun AS. Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy. Invest Ophthalmol Vis Sci 2014;55:216-25. [PMID: 24334445 DOI: 10.1167/iovs.13-12689] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
3 Su TH, Kao JH, Liu CJ. Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. Int J Mol Sci. 2014;15:10578-10604. [PMID: 24927147 DOI: 10.3390/ijms150610578] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
4 Wang H, Jiang Y, Lu M, Sun B, Qiao X, Xue D, Zhang W. STX12 lncRNA/miR-148a/SMAD5 participate in the regulation of pancreatic stellate cell activation through a mechanism involving competing endogenous RNA. Pancreatology 2017;17:237-46. [PMID: 28202235 DOI: 10.1016/j.pan.2017.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Vucur M, Roderburg C, Kaiser L, Schneider AT, Roy S, Loosen SH, Luedde M, Trautwein C, Koch A, Tacke F, Luedde T. Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment. Dis Markers 2018;2018:1983421. [PMID: 29606984 DOI: 10.1155/2018/1983421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bertero T, Cottrill KA, Annis S, Bhat B, Gochuico BR, Osorio JC, Rosas I, Haley KJ, Corey KE, Chung RT, Nelson Chau B, Chan SY. A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Sci Rep 2015;5:18277. [PMID: 26667495 DOI: 10.1038/srep18277] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
7 Liston A, Papadopoulou AS, Danso-abeam D, Dooley J. MicroRNA-29 in the adaptive immune system: setting the threshold. Cell Mol Life Sci 2012;69:3533-41. [DOI: 10.1007/s00018-012-1124-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
8 Heller KN, Mendell JT, Mendell JR, Rodino-Klapac LR. MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin. JCI Insight 2017;2:93309. [PMID: 28469083 DOI: 10.1172/jci.insight.93309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
9 Wang C, Gao C, Zhuang JL, Ding C, Wang Y. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 2012;138:2127-36. [PMID: 22864815 DOI: 10.1007/s00432-012-1288-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
10 Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: MiR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis. 2011;203:1753-1762. [PMID: 21606534 DOI: 10.1093/infdis/jir186] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 10.8] [Reference Citation Analysis]
11 Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y, Yang L. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway. Signal Transduct Target Ther 2020;5:75. [PMID: 32499481 DOI: 10.1038/s41392-020-0169-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
12 Montgomery RL, Yu G, Latimer PA, Stack C, Robinson K, Dalby CM, Kaminski N, van Rooij E. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med 2014;6:1347-56. [PMID: 25239947 DOI: 10.15252/emmm.201303604] [Cited by in Crossref: 147] [Cited by in F6Publishing: 142] [Article Influence: 24.5] [Reference Citation Analysis]
13 Pombeiro I, Loosen SH, Roy S, Schueller F, Niewenhuisen L, Luedde M, Vucur M, Tacke F, Binnebösel M, Schoening W, Trautwein C, Luedde T, Neumann UP, Roderburg C. Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer. J Clin Med 2018;7:E175. [PMID: 30011858 DOI: 10.3390/jcm7070175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cai J, Yin G, Lin B, Wang X, Liu X, Chen X, Yan D, Shan G, Qu J, Wu S. Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization. J Neuroinflammation 2014;11:88. [PMID: 24886609 DOI: 10.1186/1742-2094-11-88] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
15 Murakami Y, Kawada N. MicroRNAs in hepatic pathophysiology. Hepatol Res. 2017;47:60-69. [PMID: 27101519 DOI: 10.1111/hepr.12730] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
16 Zhu C, Wang Y, Kuai W, Sun X, Chen H, Hong Z. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin Biochem. 2013;46:49-53. [PMID: 22981932 DOI: 10.1016/j.clinbiochem.2012.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
17 Asakura M, Fukami T, Nakajima M, Fujii H, Atsuda K, Itoh T, Fujiwara R. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo. Drug Metab Dispos 2017;45:237-45. [PMID: 27895112 DOI: 10.1124/dmd.116.073866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Matsuura K, Aizawa N, Enomoto H, Nishiguchi S, Toyoda H, Kumada T, Iio E, Ito K, Ogawa S, Isogawa M, Alter HJ, Tanaka Y. Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C. Open Forum Infect Dis 2018;5:ofy268. [PMID: 30443558 DOI: 10.1093/ofid/ofy268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
19 Hartling HJ, Ballegaard VC, Nielsen NS, Gaardbo JC, Nielsen SD. Immune regulation in chronic hepatitis C virus infection. Scand J Gastroenterol 2016;51:1387-97. [PMID: 27436030 DOI: 10.3109/00365521.2016.1170875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Huang YH, Yang YL, Huang FC, Tiao MM, Lin YC, Tsai MH, Wang FS. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice. Exp Biol Med (Maywood). 2018;243:13-21. [PMID: 29105510 DOI: 10.1177/1535370217741500] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
21 Moniri M, Boroumand Moghaddam A, Azizi S, Abdul Rahim R, Zuhainis Saad W, Navaderi M, Arulselvan P, Mohamad R. Molecular study of wound healing after using biosynthesized BNC/Fe3O4 nanocomposites assisted with a bioinformatics approach. Int J Nanomedicine 2018;13:2955-71. [PMID: 29861630 DOI: 10.2147/IJN.S159637] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
22 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yao Y, Song Q, Hu C, Da X, Yu Y, He Z, Xu C, Chen Q, Wang QK. Endothelial Cell Metabolic Memory Causes Cardiovascular Dysfunction In Diabetes. Cardiovasc Res 2021:cvab013. [PMID: 33483741 DOI: 10.1093/cvr/cvab013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lin YC, Chen TH, Huang YM, Wei PL, Lin JC. Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms. Biomedicines 2021;9:343. [PMID: 33805515 DOI: 10.3390/biomedicines9040343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Xiao L, Rao JN, Zou T, Liu L, Cao S, Martindale JL, Su W, Chung HK, Gorospe M, Wang JY. miR-29b represses intestinal mucosal growth by inhibiting translation of cyclin-dependent kinase 2. Mol Biol Cell 2013;24:3038-46. [PMID: 23904268 DOI: 10.1091/mbc.E13-05-0287] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
26 Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F, Luedde T. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013;8:e54612. [PMID: 23372743 DOI: 10.1371/journal.pone.0054612] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
27 Lu L, Wang J, Lu H, Zhang G, Liu Y, Wang J, Zhang Y, Shang H, Ji H, Chen X, Duan Y, Li Y. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study. Biochem Biophys Res Commun 2015;465:387-93. [PMID: 26255201 DOI: 10.1016/j.bbrc.2015.08.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
28 O'Rourke JR, Olson EN. Modulating the MicroRNArchitecture of an aging aorta. Circ Res 2011;109:1098-9. [PMID: 22034476 DOI: 10.1161/CIRCRESAHA.111.256388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
29 Zhang K, Han Y, Hu Z, Zhang Z, Shao S, Yao Q, Zheng L, Wang J, Han X, Zhang Y, Chen T, Yao Z, Han T, Hong W. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics 2019;9:3622-38. [PMID: 31281502 DOI: 10.7150/thno.32935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
30 Kim J, Wang S, Hyun J, Choi SS, Cha H, Ock M, Jung Y. Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver. PLoS One 2015;10:e0122758. [PMID: 25826335 DOI: 10.1371/journal.pone.0122758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
31 Zhao D, Luo Y, Xia Y, Zhang JJ, Xia Q. MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis. Dig Dis Sci. 2017;62:689-698. [PMID: 28083843 DOI: 10.1007/s10620-016-4411-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 O'Reilly S. Epigenetic modulation as a therapy in systemic sclerosis. Rheumatology (Oxford) 2019;58:191-6. [PMID: 29579252 DOI: 10.1093/rheumatology/key071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 2012;6:67-80. [PMID: 22149583 DOI: 10.1586/egh.11.92] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 13.4] [Reference Citation Analysis]
34 Noetel A, Elfimova N, Altmüller J, Becker C, Becker D, Lahr W, Nürnberg P, Wasmuth H, Teufel A, Büttner R. Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells. J Hepatol. 2013;58:335-341. [PMID: 23041308 DOI: 10.1016/j.jhep.2012.09.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
35 Brain O, Owens BM, Pichulik T, Allan P, Khatamzas E, Leslie A, Steevels T, Sharma S, Mayer A, Catuneanu AM. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity. 2013;39:521-536. [PMID: 24054330 DOI: 10.1016/j.immuni.2013.08.035] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 15.6] [Reference Citation Analysis]
36 Zhi S, Chen S, Li Y, Li J, Zheng Y, Yu F. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis. Dig Dis Sci 2019;64:1560-70. [DOI: 10.1007/s10620-019-5462-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
37 Janel N, Noll C. Protection and Reversal of Hepatic Fibrosis by Polyphenols. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 665-79. [DOI: 10.1016/b978-0-12-398456-2.00051-7] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
38 Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled. World J Gastroenterol 2013; 19(32): 5212-5226 [PMID: 23983424 DOI: 10.3748/wjg.v19.i32.5212] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
39 Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011;157:191-9. [PMID: 21420029 DOI: 10.1016/j.trsl.2011.01.012] [Cited by in Crossref: 214] [Cited by in F6Publishing: 209] [Article Influence: 21.4] [Reference Citation Analysis]
40 Li G, Cai G, Li D, Yin W. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma. Postgrad Med J 2014;90:106-12. [PMID: 24243965 DOI: 10.1136/postgradmedj-2013-131883] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
41 Eulenberg VM, Lidbury JA. Hepatic Fibrosis in Dogs. J Vet Intern Med. 2018;32:26-41. [PMID: 29194760 DOI: 10.1111/jvim.14891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
42 Xie G, Wang X, Zhao A, Yan J, Chen W, Jiang R, Ji J, Huang F, Zhang Y, Lei S, Ge K, Zheng X, Rajani C, Alegado RA, Liu J, Liu P, Nicholson J, Jia W. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci Rep 2017;7:45232. [PMID: 28345673 DOI: 10.1038/srep45232] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
43 Kong Y, Huang T, Zhang H, Zhang Q, Ren J, Guo X, Fan H, Liu L. The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells. Life Sci 2019;237:116902. [PMID: 31610195 DOI: 10.1016/j.lfs.2019.116902] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
44 Angelbello AJ, Chen JL, Childs-Disney JL, Zhang P, Wang ZF, Disney MD. Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. Chem Rev 2018;118:1599-663. [PMID: 29322778 DOI: 10.1021/acs.chemrev.7b00504] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
45 Ladak SS, Ward C, Ali S. The potential role of microRNAs in lung allograft rejection. The Journal of Heart and Lung Transplantation 2016;35:550-9. [DOI: 10.1016/j.healun.2016.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
46 Sheen-Chen SM, Lin CR, Chen KH, Yang CH, Lee CT, Huang HW, Huang CY. Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. J Gastroenterol 2014;49:1285-97. [PMID: 24097032 DOI: 10.1007/s00535-013-0892-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
47 Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012;142:1431-43. [PMID: 22504185 DOI: 10.1053/j.gastro.2012.04.007] [Cited by in Crossref: 201] [Cited by in F6Publishing: 197] [Article Influence: 22.3] [Reference Citation Analysis]
48 Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J. 2014;11:64. [PMID: 24690114 DOI: 10.1186/1743-422x-11-64] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
49 Zanotti S, Gibertini S, Curcio M, Savadori P, Pasanisi B, Morandi L, Cornelio F, Mantegazza R, Mora M. Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:1451-64. [DOI: 10.1016/j.bbadis.2015.04.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]
50 Oke SL, Lee K, Papp R, Laviolette SR, Hardy DB. In Utero Exposure to Δ9-Tetrahydrocannabinol Leads to Postnatal Catch-Up Growth and Dysmetabolism in the Adult Rat Liver. Int J Mol Sci 2021;22:7502. [PMID: 34299119 DOI: 10.3390/ijms22147502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Porciuncula A, Zapata N, Guruceaga E, Agirre X, Barajas M, Prosper F. MicroRNA signatures of iPSCs and endoderm-derived tissues. Gene Expr Patterns 2013;13:12-20. [PMID: 22982176 DOI: 10.1016/j.gep.2012.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
52 Bhattacharyya S, Tamaki Z, Wang W, Hinchcliff M, Hoover P, Getsios S, White ES, Varga J. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med 2014;6:232ra50. [PMID: 24739758 DOI: 10.1126/scitranslmed.3008264] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 18.9] [Reference Citation Analysis]
53 Sun X, Zhang L, Jiang Y, Li A, Zhu D, Wu J, Duan Y. The role of let-7b in the inhibition of hepatic stellate cell activation by rSjP40. PLoS Negl Trop Dis 2021;15:e0009472. [PMID: 34161325 DOI: 10.1371/journal.pntd.0009472] [Reference Citation Analysis]
54 Ding H, Zhou Y, Huang H. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF-κB signalling in a mouse model of hypertension. Clin Exp Pharmacol Physiol 2019;46:246-54. [PMID: 30304543 DOI: 10.1111/1440-1681.13042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Yu-Wai-Man C, Khaw PT. Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers. Adv Wound Care (New Rochelle) 2016;5:390-402. [PMID: 27679750 DOI: 10.1089/wound.2015.0677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Roy S, Benz F, Luedde T, Roderburg C. The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis. Hepatobiliary Surg Nutr 2015;4:24-33. [PMID: 25713802 DOI: 10.3978/j.issn.2304-3881.2015.01.05] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
57 Butz H, Rácz K, Hunyady L, Patócs A. Crosstalk between TGF-β signaling and the microRNA machinery. Trends Pharmacol Sci 2012;33:382-93. [PMID: 22613783 DOI: 10.1016/j.tips.2012.04.003] [Cited by in Crossref: 147] [Cited by in F6Publishing: 145] [Article Influence: 16.3] [Reference Citation Analysis]
58 Meng F, Glaser SS, Francis H, Yang F, Han Y, Stokes A, Staloch D, McCarra J, Liu J, Venter J, Zhao H, Liu X, Francis T, Swendsen S, Liu CG, Tsukamoto H, Alpini G. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol. 2012;181:804-817. [PMID: 22841474 DOI: 10.1016/j.ajpath.2012.06.010] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 10.8] [Reference Citation Analysis]
59 Huang S, Xie Y, Yang P, Chen P, Zhang L. HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells. PLoS One. 2014;9:e81730. [PMID: 24416131 DOI: 10.1371/journal.pone.0081730] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
60 Yano H, Hamanaka R, Nakamura M, Sumiyoshi H, Matsuo N, Yoshioka H. Smad, but not MAPK, pathway mediates the expression of type I collagen in radiation induced fibrosis. Biochem Biophys Res Commun 2012;418:457-63. [PMID: 22277670 DOI: 10.1016/j.bbrc.2012.01.039] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
61 Nakano M, Fukami T, Gotoh S, Takamiya M, Aoki Y, Nakajima M. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence. J Biol Chem 2016;291:894-903. [PMID: 26601943 DOI: 10.1074/jbc.M115.699363] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
62 Gomes PR, Graciano MF, Pantaleão LC, Rennó AL, Rodrigues SC, Velloso LA, Latorraca MQ, Carpinelli AR, Anhê GF, Bordin S. Long-term disruption of maternal glucose homeostasis induced by prenatal glucocorticoid treatment correlates with miR-29 upregulation. American Journal of Physiology-Endocrinology and Metabolism 2014;306:E109-20. [DOI: 10.1152/ajpendo.00364.2013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
63 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
64 Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouyé S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 2013;8:e58014. [PMID: 23469132 DOI: 10.1371/journal.pone.0058014] [Cited by in Crossref: 140] [Cited by in F6Publishing: 129] [Article Influence: 17.5] [Reference Citation Analysis]
65 Zhu J, Wang C, Zhang X, Qiu T, Ma Y, Li X, Pang H, Xiong J, Yang X, Pan C, Xie J, Zhang J. Correlation analysis of microribonucleic acid-155 and microribonucleic acid-29 with type 2 diabetes mellitus, and the prediction and verification of target genes. J Diabetes Investig 2021;12:165-75. [PMID: 32579760 DOI: 10.1111/jdi.13334] [Reference Citation Analysis]
66 Darby IA, Zakuan N, Billet F, Desmoulière A. The myofibroblast, a key cell in normal and pathological tissue repair. Cell Mol Life Sci 2016;73:1145-57. [PMID: 26681260 DOI: 10.1007/s00018-015-2110-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 135] [Article Influence: 24.3] [Reference Citation Analysis]
67 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
68 Lin HY, Yang YL, Wang PW, Wang FS, Huang YH. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Cells 2020;9:E1041. [PMID: 32331364 DOI: 10.3390/cells9041041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
69 Li J, Cen B, Chen S, He Y. MicroRNA-29b inhibits TGF-β1-induced fibrosis via regulation of the TGF-β1/Smad pathway in primary human endometrial stromal cells. Mol Med Rep 2016;13:4229-37. [PMID: 27035110 DOI: 10.3892/mmr.2016.5062] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
70 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
71 Nijhuis A, Curciarello R, Mehta S, Feakins R, Bishop CL, Lindsay JO, Silver A. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8. Cell Tissue Res 2017;368:325-35. [PMID: 28190086 DOI: 10.1007/s00441-017-2576-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
72 Schueller F, Roy S, Loosen SH, Alder J, Koppe C, Schneider AT, Wandrer F, Bantel H, Vucur M, Mi QS, Trautwein C, Luedde T, Roderburg C. miR-223 represents a biomarker in acute and chronic liver injury. Clin Sci (Lond) 2017;131:1971-87. [PMID: 28646120 DOI: 10.1042/CS20170218] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
73 Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 2013;9:e1003291. [PMID: 23459460 DOI: 10.1371/journal.pgen.1003291] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 19.1] [Reference Citation Analysis]
74 García R, Salido-Medina AB, Gil A, Merino D, Gómez J, Villar AV, González-Vílchez F, Hurlé MA, Nistal JF. Sex-Specific Regulation of miR-29b in the Myocardium Under Pressure Overload is Associated with Differential Molecular, Structural and Functional Remodeling Patterns in Mice and Patients with Aortic Stenosis. Cells 2020;9:E833. [PMID: 32235655 DOI: 10.3390/cells9040833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
75 Zhao Y, Wang Z, Zhou J, Feng D, Li Y, Hu Y, Zhang F, Chen Z, Wang G, Ma X, Tian X, Yao J. LncRNA Mical2/miR-203a-3p sponge participates in epithelial-mesenchymal transition by targeting p66Shc in liver fibrosis. Toxicol Appl Pharmacol 2020;403:115125. [PMID: 32659284 DOI: 10.1016/j.taap.2020.115125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Li L, Huang Y, Zhang Z. Expression profile of miRNAs involved in the hepatoprotective effects of curcumin against oxidative stress in Nile tilapia. Aquat Toxicol 2021;237:105896. [PMID: 34174576 DOI: 10.1016/j.aquatox.2021.105896] [Reference Citation Analysis]
77 Niu X, Nong S, Gong J, Zhang X, Tang H, Zhou T, Li W. Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC. Ir J Med Sci 2020;189:1295-304. [PMID: 32270431 DOI: 10.1007/s11845-020-02210-w] [Reference Citation Analysis]
78 Dong XC, Chowdhury K, Huang M, Kim HG. Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxid Redox Signal 2021. [PMID: 33906425 DOI: 10.1089/ars.2021.0076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yang D, Gao YH, Tan KB, Zuo ZX, Yang WX, Hua X, Li PJ, Zhang Y, Wang G. Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles. Gene Ther. 2013;20:1140-1148. [PMID: 23966015 DOI: 10.1038/gt.2013.41] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
80 Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 2015;50:480-490. [PMID: 25155445 DOI: 10.1007/s00535-014-0986-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
81 Page A, Mann DA. Epigenetic regulation of liver fibrosis. Clin Res Hepatol Gastroenterol 2015;39 Suppl 1:S64-8. [PMID: 26189981 DOI: 10.1016/j.clinre.2015.05.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
82 Xu P, Guo A, Xu J, Yao J, Chen H, Wang F, Zhu C. Evaluation of a combinational use of serum microRNAs as biomarkers for liver diseases. Clin Res Hepatol Gastroenterol 2017;41:254-61. [PMID: 28215541 DOI: 10.1016/j.clinre.2016.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
83 Ding S, Liu D, Wang L, Wang G, Zhu Y. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway. J Pharmacol Exp Ther 2020;372:128-35. [PMID: 31481517 DOI: 10.1124/jpet.119.256982] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
84 Herrera J, Beisang DJ, Peterson M, Forster C, Gilbertsen A, Benyumov A, Smith K, Korenczuk CE, Barocas VH, Guenther K, Hite R, Zhang L, Henke CA, Bitterman PB. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis. Am J Respir Crit Care Med 2018;198:486-96. [PMID: 29579397 DOI: 10.1164/rccm.201709-1823OC] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
85 Cuiqiong W, Chao X, Xinling F, Yinyan J. Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway. Artif Cells Nanomed Biotechnol 2020;48:473-8. [PMID: 31975615 DOI: 10.1080/21691401.2020.1717507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
86 Yu X, Odenthal M, Fries JW. Exosomes as miRNA Carriers: Formation-Function-Future. Int J Mol Sci. 2016;17. [PMID: 27918449 DOI: 10.3390/ijms17122028] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 21.8] [Reference Citation Analysis]
87 Fernandez M. Molecular pathophysiology of portal hypertension. Hepatology. 2015;61:1406-1415. [PMID: 25092403 DOI: 10.1002/hep.27343] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 12.0] [Reference Citation Analysis]
88 Yang YL, Wang FS, Lin HY, Huang YH. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha. Int J Mol Sci 2020;21:E3636. [PMID: 32455716 DOI: 10.3390/ijms21103636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
89 Wang MX, Zhao J, Zhang H, Li K, Niu LZ, Wang YP, Zheng YJ. Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update. Oxid Med Cell Longev 2020;2020:9410952. [PMID: 32273949 DOI: 10.1155/2020/9410952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
90 Mannaerts I, Eysackers N, Onyema OO, Van Beneden K, Valente S, Mai A, Odenthal M, van Grunsven LA. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS One. 2013;8:e55786. [PMID: 23383282 DOI: 10.1371/journal.pone.0055786] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
91 Seki E, Park E, Fujimoto J. Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res 2011;41:597-610. [PMID: 21696522 DOI: 10.1111/j.1872-034X.2011.00822.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
92 Yang X, Ni J, Li Y, Zou L, Guo T, Li Y, Chu L, Zhu Z. LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a. Dose Response 2020;18:1559325820949071. [PMID: 33117089 DOI: 10.1177/1559325820949071] [Reference Citation Analysis]
93 Dawson K, Wakili R, Ordög B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kääb S, Nattel S. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013;127:1466-75, 1475e1-28. [PMID: 23459615 DOI: 10.1161/CIRCULATIONAHA.112.001207] [Cited by in Crossref: 136] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
94 Mohr R, Özdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, Hellberg T, Loosen SH, Luedde T, Tacke F, Hammerich L, Roderburg C. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. Int J Mol Sci 2021;22:1492. [PMID: 33540837 DOI: 10.3390/ijms22031492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Zhu J, Xiong G, Fu H, Evers BM, Zhou BP, Xu R. Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network. Cancer Res 2015;75:1580-91. [PMID: 25744716 DOI: 10.1158/0008-5472.CAN-14-1027] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 9.7] [Reference Citation Analysis]
96 Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology. 2015;61:141-152. [PMID: 25131933 DOI: 10.1002/hep.27379] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
97 Jing F, Geng Y, Xu XY, Xu HY, Shi JS, Xu ZH. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1. Int J Mol Sci 2019;20:E796. [PMID: 30781750 DOI: 10.3390/ijms20040796] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
98 Stamataki Z, Swadling L. The liver as an immunological barrier redefined by single-cell analysis. Immunology 2020;160:157-70. [PMID: 32176810 DOI: 10.1111/imm.13193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
99 Zhu Y, Li W, Zhu D, Zhou J. microRNA profiling in the aqueous humor of highly myopic eyes using next generation sequencing. Exp Eye Res 2020;195:108034. [PMID: 32333905 DOI: 10.1016/j.exer.2020.108034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Liu C, Li L, Ge M, Gu L, Wang M, Zhang K, Su Y, Zhang Y, Liu C, Lan M, Yu Y, Wang T, Li Q, Zhao Y, Yu Z, Li N, Meng Q. Overexpression of miR-29 Leads to Myopathy that Resemble Pathology of Ullrich Congenital Muscular Dystrophy. Cells 2019;8:E459. [PMID: 31096686 DOI: 10.3390/cells8050459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
101 Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ, McConnell MV, Dalman RL, Spin JM, Tsao PS. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012;122:497-506. [PMID: 22269326 DOI: 10.1172/JCI61598] [Cited by in Crossref: 206] [Cited by in F6Publishing: 116] [Article Influence: 22.9] [Reference Citation Analysis]
102 Moravek MB, Yin P, Ono M, Coon JS 5th, Dyson MT, Navarro A, Marsh EE, Chakravarti D, Kim JJ, Wei JJ, Bulun SE. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. Hum Reprod Update 2015;21:1-12. [PMID: 25205766 DOI: 10.1093/humupd/dmu048] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 10.9] [Reference Citation Analysis]
103 Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X. Pre-microRNA and mature microRNA in human mitochondria. PLoS One 2011;6:e20220. [PMID: 21637849 DOI: 10.1371/journal.pone.0020220] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 19.1] [Reference Citation Analysis]
104 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
105 Lidbury J. Potential of circulating microRNAs as biomarkers in veterinary medicine. Vet J 2016;212:78-9. [PMID: 27256029 DOI: 10.1016/j.tvjl.2016.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
106 Li Y, Huang J, Guo M, Zuo X. MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis. Genomics Proteomics Bioinformatics 2015;13:234-41. [PMID: 26365208 DOI: 10.1016/j.gpb.2015.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
107 Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, Chen J, Dong L, Zhang J. miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun. 2012;417:1100-1105. [PMID: 22227196 DOI: 10.1016/j.bbrc.2011.12.121] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 10.2] [Reference Citation Analysis]
108 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Morishita A, Yoneyama H, Iwama H, Fujita K, Watanabe M, Hirose K, Tadokoro T, Oura K, Sakamoto T, Mimura S, Nomura T, Oryu M, Himoto T, Shimotohno K, Masaki T. Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir. Oncotarget 2018;9:32054-62. [PMID: 30174796 DOI: 10.18632/oncotarget.25889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
110 Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:542-552. [PMID: 23689081 DOI: 10.1038/nrgastro.2013.87] [Cited by in Crossref: 367] [Cited by in F6Publishing: 359] [Article Influence: 45.9] [Reference Citation Analysis]
111 Sarr O, Blake A, Thompson JA, Zhao L, Rabicki K, Walsh JC, Welch I, Regnault TR. The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig. J Physiol 2016;594:1753-72. [PMID: 26662996 DOI: 10.1113/JP271777] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
112 Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ, Li N. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. J Dig Dis. 2014;15:614-621. [PMID: 25138057 DOI: 10.1111/1751-2980.12185] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
113 Chen J, Yang F, Yu X, Yu Y, Gong Y. Cyclosporine A promotes cell proliferation, collagen and α-smooth muscle actin expressions in rat gingival fibroblasts by Smad3 activation and miR-29b suppression. J Periodont Res 2016;51:735-47. [DOI: 10.1111/jre.12350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
114 Li C, Zhang P, Gu J. miR-29a modulates tumor necrosis factor-α-induced osteogenic inhibition by targeting Wnt antagonists. Dev Growth Differ 2015;57:264-73. [PMID: 25846459 DOI: 10.1111/dgd.12207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
115 Ko JY, Lee MS, Lian WS, Weng WT, Sun YC, Chen YS, Wang FS. MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF. Sci Rep 2017;7:3584. [PMID: 28620193 DOI: 10.1038/s41598-017-03616-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
116 Yu F, Jiang Z, Chen B, Dong P, Zheng J. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6. J Mol Med (Berl) 2017;95:1191-202. [PMID: 28864835 DOI: 10.1007/s00109-017-1586-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
117 Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol. 2013;3:977-1010. [PMID: 23720337 DOI: 10.1002/cphy.c120020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 102] [Article Influence: 6.3] [Reference Citation Analysis]
118 Wang R, Fu T, You K, Li S, Zhao N, Yang J, Zhuang SM. Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells. FASEB J 2018;32:3936-45. [PMID: 29465312 DOI: 10.1096/fj.201701199R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
119 Ge S, Wang X, Xie J, Yi X, Liu F. Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats. Annals of Hepatology 2014;13:439-49. [DOI: 10.1016/s1665-2681(19)30851-8] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
120 Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Sci Rep. 2015;5:15026. [PMID: 26456479 DOI: 10.1038/srep15026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
121 Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, Shi J, Lu C, Ning B, Zhang J. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 2015;35:1234-1243. [PMID: 25142507 DOI: 10.1111/liv.12660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
122 Chen HY, Zhong X, Huang XR, Meng XM, You Y, Chung AC, Lan HY. MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol Ther 2014;22:842-53. [PMID: 24445937 DOI: 10.1038/mt.2013.235] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 13.5] [Reference Citation Analysis]
123 [DOI: 10.1101/082511] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Wei YF, Cui GY, Ye P, Chen JN, Diao HY. MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World J Gastroenterol 2013; 19(30): 4867-4876 [PMID: 23946591 DOI: 10.3748/wjg.v19.i30.4867] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
125 van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012;11:860-72. [PMID: 23080337 DOI: 10.1038/nrd3864] [Cited by in Crossref: 427] [Cited by in F6Publishing: 410] [Article Influence: 47.4] [Reference Citation Analysis]
126 Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147:765-783.e4. [PMID: 25046161 DOI: 10.1053/j.gastro.2014.07.018] [Cited by in Crossref: 365] [Cited by in F6Publishing: 348] [Article Influence: 52.1] [Reference Citation Analysis]
127 Wang J, Wang Y, Wang Y, Ma Y, Lan Y, Yang X. Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. J Biol Chem. 2013;288:10418-10426. [PMID: 23426367 DOI: 10.1074/jbc.m112.444463] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
128 Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
129 Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, Men R, Li P, Dong B, Liu L, Fu X, Xu H, Aqeilan RI, Wei YQ, Yang L, Peng Y. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis. 2018;9:718. [PMID: 29915227 DOI: 10.1038/s41419-018-0752-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
130 Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. Int J Mol Sci. 2018;19:3857. [PMID: 30513996 DOI: 10.3390/ijms19123857] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
131 Wang Q, Yin Y, Zhang W. Ghrelin Restores the Disruption of the Circadian Clock in Steatotic Liver. Int J Mol Sci 2018;19:E3134. [PMID: 30322022 DOI: 10.3390/ijms19103134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
132 Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M. Plasma MicroRNA as a novel diagnostic. Clin Chim Acta 2019;499:98-107. [PMID: 31499022 DOI: 10.1016/j.cca.2019.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
133 Bissoondial TL, Pellicano AJ, Goldberg ID, Narayan P. Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis. Mol Omics 2021. [PMID: 34757352 DOI: 10.1039/d1mo00274k] [Reference Citation Analysis]
134 Cheng J, Wang Y, Wang D, Wu Y. Identification of Collagen 1 as a Post-transcriptional Target of miR-29b in Skin Fibroblasts: Therapeutic Implication for Scar Reduction. The American Journal of the Medical Sciences 2013;346:98-103. [DOI: 10.1097/maj.0b013e318267680d] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
135 Caviglia JM, Yan J, Jang MK, Gwak GY, Affo S, Yu L, Olinga P, Friedman RA, Chen X, Schwabe RF. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 2018;67:2414-29. [PMID: 29091291 DOI: 10.1002/hep.29627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
136 Zhou L, Wang L, Lu L, Jiang P, Sun H, Wang H. Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS One 2012;7:e33766. [PMID: 22438993 DOI: 10.1371/journal.pone.0033766] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 9.9] [Reference Citation Analysis]
137 Benz F, Bogen A, Praktiknjo M, Jansen C, Meyer C, Wree A, Demir M, Loosen S, Vucur M, Schierwagen R, Tacke F, Trebicka J, Roderburg C. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis. PLoS One 2020;15:e0231701. [PMID: 32302330 DOI: 10.1371/journal.pone.0231701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Matsuura K, De Giorgi V, Schechterly C, Wang RY, Farci P, Tanaka Y, Alter HJ. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C. Hepatology. 2016;64:732-745. [PMID: 27227815 DOI: 10.1002/hep.28660] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
139 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
140 Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 suppresses metastasis and modulates the tumor microenvironment by regulating microRNA-29b expression. Nat Cell Biol. 2013;15:201-213. [PMID: 23354167 DOI: 10.1038/ncb2672] [Cited by in Crossref: 239] [Cited by in F6Publishing: 224] [Article Influence: 29.9] [Reference Citation Analysis]
141 Roderburg C, Trautwein C, Luedde T. MicroRNA-199a/b-3p: a new star in the liver microcosmos. Hepatology 2011;54:729-31. [PMID: 21793019 DOI: 10.1002/hep.24456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
142 Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, De Wever O, Mareel M, Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180:1340-1355. [PMID: 22387320 DOI: 10.1016/j.ajpath.2012.02.004] [Cited by in Crossref: 789] [Cited by in F6Publishing: 762] [Article Influence: 87.7] [Reference Citation Analysis]
143 Han W, Han Y, Liu X, Shang X. Effect of miR-29a inhibition on ventricular hypertrophy induced by pressure overload. Cell Biochem Biophys. 2015;71:821-826. [PMID: 25308856 DOI: 10.1007/s12013-014-0269-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
144 Jiang L, Qiu W, Zhou Y, Wen P, Fang L, Cao H, Zen K, He W, Zhang C, Dai C, Yang J. A microRNA-30e/mitochondrial uncoupling protein 2 axis mediates TGF-β1-induced tubular epithelial cell extracellular matrix production and kidney fibrosis. Kidney Int 2013;84:285-96. [PMID: 23515048 DOI: 10.1038/ki.2013.80] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
145 Luedde M, Roy S, Hippe HJ, Cardenas DV, Spehlmann M, Vucur M, Hoening P, Loosen S, Frey N, Trautwein C, Luedde T, Koch A, Tacke F, Roderburg C. Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients. Sci Rep 2018;8:9750. [PMID: 29950701 DOI: 10.1038/s41598-018-28201-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Sassi Y, Avramopoulos P, Ramanujam D, Grüter L, Werfel S, Giosele S, Brunner AD, Esfandyari D, Papadopoulou AS, De Strooper B, Hübner N, Kumarswamy R, Thum T, Yin X, Mayr M, Laggerbauer B, Engelhardt S. Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling. Nat Commun 2017;8:1614. [PMID: 29158499 DOI: 10.1038/s41467-017-01737-4] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 22.0] [Reference Citation Analysis]
147 Kitab B, Alj HS, Ezzikouri S, Benjelloun S. MicroRNAs as Important Players in Host-hepatitis B Virus Interactions. J Clin Transl Hepatol 2015;3:149-61. [PMID: 26357642 DOI: 10.14218/JCTH.2015.00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
148 Munoz-garrido P, Marzioni M, Hijona E, Bujanda L, Banales JM. MicroRNAs in Liver Diseases. In: Lawrie CH, editor. MicroRNAs in Medicine. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 509-22. [DOI: 10.1002/9781118300312.ch31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Chau BN, Brenner DA. What goes up must come down: the emerging role of microRNA in fibrosis. Hepatology. 2011;53:4-6. [PMID: 21254156 DOI: 10.1002/hep.24071] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
150 Tavasolian F, Inman RD. Gut microbiota-microRNA interactions in ankylosing spondylitis. Autoimmun Rev 2021;20:102827. [PMID: 33864943 DOI: 10.1016/j.autrev.2021.102827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011;22:1668-81. [PMID: 21852586 DOI: 10.1681/ASN.2010111168] [Cited by in Crossref: 289] [Cited by in F6Publishing: 152] [Article Influence: 28.9] [Reference Citation Analysis]
152 Wu Y, Shi W, Tang T, Wang Y, Yin X, Chen Y, Zhang Y, Xing Y, Shen Y, Xia T, Guo C, Pan Y, Jin L. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death Dis 2019;10:176. [PMID: 30792382 DOI: 10.1038/s41419-019-1437-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
153 Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ, Lan HY. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 2012;20:1251-60. [PMID: 22395530 DOI: 10.1038/mt.2012.36] [Cited by in Crossref: 205] [Cited by in F6Publishing: 198] [Article Influence: 22.8] [Reference Citation Analysis]
154 Fu Q, Shi H, Shi M, Meng L, Zhang H, Ren Y, Guo F, Jia B, Wang P, Ni W, Chen C. bta-miR-29b attenuates apoptosis by directly targeting caspase-7 and NAIF1 and suppresses bovine viral diarrhea virus replication in MDBK cells. Can J Microbiol 2014;60:455-60. [PMID: 24965127 DOI: 10.1139/cjm-2014-0277] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
155 Zhang Z, Shen S. Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study. Medicine (Baltimore) 2017;96:e8795. [PMID: 29310356 DOI: 10.1097/MD.0000000000008795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
156 Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J, Nieuwenhuijsen L, Luedde M, Frey N, Tacke F, Trautwein C, Luedde T. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med 2013;45:e42. [PMID: 24052167 DOI: 10.1038/emm.2013.81] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
157 Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Reference Citation Analysis]
158 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 99] [Cited by in F6Publishing: 55] [Article Influence: 16.5] [Reference Citation Analysis]
159 Yang X, Dan X, Men R, Ma L, Wen M, Peng Y, Yang L. MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI. Life Sciences 2017;187:22-30. [DOI: 10.1016/j.lfs.2017.08.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
160 Sun Y, Guo F, Bagnoli M, Xue FX, Sun BC, Shmulevich I, Mezzanzanica D, Chen KX, Sood AK, Yang D, Zhang W. Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer. Chin J Cancer 2015;34:28-40. [PMID: 25556616 DOI: 10.5732/cjc.014.10284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
161 Izawa T, Horiuchi T, Atarashi M, Kuwamura M, Yamate J. Anti-fibrotic Role of miR-214 in Thioacetamide-induced Liver Cirrhosis in Rats. Toxicol Pathol. 2015;43:844-851. [PMID: 25755099 DOI: 10.1177/0192623315573587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
162 Roy S, Benz F, Vargas Cardenas D, Vucur M, Gautheron J, Schneider A, Hellerbrand C, Pottier N, Alder J, Tacke F, Trautwein C, Roderburg C, Luedde T. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis: miR-193 and miR-30c in liver fibrosis. Journal of Digestive Diseases 2015;16:513-24. [DOI: 10.1111/1751-2980.12266] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
163 Li F, Ma N, Zhao R, Wu G, Zhang Y, Qiao Y, Han D, Xu Y, Xiang Y, Yan B, Jin J, Lv G, Wang L, Xu C, Gao X, Luo S. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice. J Cell Mol Med 2014;18:966-74. [PMID: 24801603 DOI: 10.1111/jcmm.12293] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
164 Yang YL, Wang FS, Li SC, Tiao MM, Huang YH. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Int J Mol Sci 2017;18:E192. [PMID: 28106784 DOI: 10.3390/ijms18010192] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
165 Ceccarelli S, Panera N, Gnani D, Nobili V. Dual Role of MicroRNAs in NAFLD. Int J Mol Sci. 2013;14:8437-8455. [PMID: 23594995 DOI: 10.3390/ijms14048437] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
166 Wang JY, Xiao L, Wang JY. Posttranscriptional regulation of intestinal epithelial integrity by noncoding RNAs. Wiley Interdiscip Rev RNA 2017;8. [PMID: 27704722 DOI: 10.1002/wrna.1399] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
167 Gu T, Shen B, Li B, Guo Y, Li F, Ma Z, Chen L, Zhang Q, Qu Y, Dong H, Cai X, Lu L. miR-30c inhibits angiogenesis by targeting delta-like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis. FASEB J 2021;35:e21571. [PMID: 33861889 DOI: 10.1096/fj.202002694R] [Reference Citation Analysis]
168 Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, Lan HY, Sung JJ, Yu J. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget. 2015;6:7325-7338. [PMID: 25356754 DOI: 10.18632/oncotarget.2621] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 20.6] [Reference Citation Analysis]
169 [DOI: 10.1101/529784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Ji L, Lin Z, Wan Z, Xia S, Jiang S, Cen D, Cai L, Xu J, Cai X. miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR. Cell Death Dis 2020;11:250. [PMID: 32313144 DOI: 10.1038/s41419-020-2413-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
171 Chen W, Yan X, Yang A, Xu A, Huang T, You H. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis. Epigenomics 2020;12:53-67. [PMID: 31833387 DOI: 10.2217/epi-2019-0104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
172 Kweon M, Kim JY, Jun JH, Kim GJ. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. Int J Mol Sci 2020;22:E239. [PMID: 33383629 DOI: 10.3390/ijms22010239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Xu MQ, Jiang H, Zhang LQ, Sun XL, Luo D, Fu Y, Gao Y, Yuan B, Zhang JB. MiR-29b affects the secretion of PROG and promotes the proliferation of bovine corpus luteum cells. PLoS One 2018;13:e0195562. [PMID: 29617446 DOI: 10.1371/journal.pone.0195562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
174 Sun X, Nkennor B, Mastikhina O, Soon K, Nunes SS. Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol. 2020;101:78-86. [PMID: 31791693 DOI: 10.1016/j.semcdb.2019.10.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
175 Goldschmidt I, Thum T, Baumann U. Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease. J Clin Med 2016;5:E28. [PMID: 26927196 DOI: 10.3390/jcm5030028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
176 Ko JY, Chuang PC, Ke HJ, Chen YS, Sun YC, Wang FS. MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation. Bone 2015;81:80-8. [PMID: 26141838 DOI: 10.1016/j.bone.2015.06.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
177 Hellberg T, Mohr R, Geisler L, Knorr J, Wree A, Demir M, Benz F, Lambrecht J, Loosen SH, Tacke F, Roderburg C, Jann H, Özdirik B. Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors. PLoS One 2020;15:e0244504. [PMID: 33382770 DOI: 10.1371/journal.pone.0244504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Kumar V, Mondal G, Dutta R, Mahato RI. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis. Biomaterials. 2016;76:144-156. [PMID: 26524535 DOI: 10.1016/j.biomaterials.2015.10.047] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
179 Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol 2012;3:138. [PMID: 22661952 DOI: 10.3389/fphys.2012.00138] [Cited by in Crossref: 80] [Cited by in F6Publishing: 90] [Article Influence: 8.9] [Reference Citation Analysis]
180 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
181 Czaja AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol 2016; 22(42): 9257-9278 [PMID: 27895415 DOI: 10.3748/wjg.v22.i42.9257] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
182 Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, Huang YH. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis. 2014;19:30-41. [PMID: 24052410 DOI: 10.1007/s10495-013-0909-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
183 韦君, 樊晓明. microRNAs在肝脏中的作用. 世界华人消化杂志 2012; 20(1): 1-8 [DOI: 10.11569/wcjd.v20.i1.1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
184 Gupta G, Khadem F, Uzonna JE. Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity. Cytokine 2019;124:154542. [PMID: 30241896 DOI: 10.1016/j.cyto.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
185 Zhu D, Yang C, Shen P, Chen L, Chen J, Sun X, Duan L, Zhang L, Zhu J, Duan Y. rSjP40 suppresses hepatic stellate cell activation by promoting microRNA-155 expression and inhibiting STAT5 and FOXO3a expression. J Cell Mol Med 2018;22:5486-93. [PMID: 30091834 DOI: 10.1111/jcmm.13819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
186 Vickers KC, Shoucri BM, Levin MG, Wu H, Pearson DS, Osei-Hwedieh D, Collins FS, Remaley AT, Sethupathy P. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 2013;57:533-42. [PMID: 22777896 DOI: 10.1002/hep.25846] [Cited by in Crossref: 152] [Cited by in F6Publishing: 150] [Article Influence: 16.9] [Reference Citation Analysis]
187 Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193:225-231. [PMID: 21803030 DOI: 10.1016/j.cbi.2011.07.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 17.1] [Reference Citation Analysis]
188 Duică F, Condrat CE, Dănila CA, Boboc AE, Radu MR, Xiao J, Li X, Creţoiu SM, Suciu N, Creţoiu D, Predescu DV. MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies. Front Oncol 2020;10:591181. [PMID: 33194751 DOI: 10.3389/fonc.2020.591181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
189 Li L, Ran J, Li L, Chen G, Zhang S, Wang Y. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in vivo and in vitro. Mol Med Rep 2020;21:1861-71. [PMID: 32319630 DOI: 10.3892/mmr.2020.10997] [Reference Citation Analysis]
190 曾志萍, 郭津生. 肝纤维化发生机制及治疗研究进展. 世界华人消化杂志 2017; 25(7): 569-575 [DOI: 10.11569/wcjd.v25.i7.569] [Reference Citation Analysis]
191 Coll M, El Taghdouini A, Perea L, Mannaerts I, Vila-Casadesús M, Blaya D, Rodrigo-Torres D, Affò S, Morales-Ibanez O, Graupera I, Lozano JJ, Najimi M, Sokal E, Lambrecht J, Ginès P, van Grunsven LA, Sancho-Bru P. Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells. Sci Rep 2015;5:11549. [PMID: 26096707 DOI: 10.1038/srep11549] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 10.0] [Reference Citation Analysis]
192 Fang Y, Yu X, Liu Y, Kriegel AJ, Heng Y, Xu X, Liang M, Ding X. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. Am J Physiol Renal Physiol 2013;304:F1274-82. [PMID: 23467423 DOI: 10.1152/ajprenal.00287.2012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
193 Liang C, Bu S, Fan X. Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-β1/Smad3. Cell Biochem Funct 2016;34:326-33. [PMID: 27273381 DOI: 10.1002/cbf.3193] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
194 Sakuma H, Hagiwara S, Kantharidis P, Gohda T, Suzuki Y. Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs. Front Pharmacol 2020;11:587689. [PMID: 33364960 DOI: 10.3389/fphar.2020.587689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Sodroski C, Lowey B, Hertz L, Jake Liang T, Li Q. MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors. Virol Sin. 2019;34:197-210. [PMID: 30456659 DOI: 10.1007/s12250-018-0055-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
196 Liu J, Eischeid AN, Chen XM. Col1A1 production and apoptotic resistance in TGF-β1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS One. 2012;7:e51371. [PMID: 23236489 DOI: 10.1371/journal.pone.0051371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
197 Mohammadi H, Hemmatzadeh M, Babaie F, Gowhari Shabgah A, Azizi G, Hosseini F, Majidi J, Baradaran B. MicroRNA implications in the etiopathogenesis of ankylosing spondylitis. J Cell Physiol 2018;233:5564-73. [PMID: 29377110 DOI: 10.1002/jcp.26500] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
198 Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One. 2011;6:e16081. [PMID: 21283674 DOI: 10.1371/journal.pone.0016081;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C, Weiskirchen R, Frey N. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol. 2013;58:736-742. [PMID: 23183523 DOI: 10.1016/j.jhep.2012.11.022] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
200 Gong X, Wang X, Zhou F. Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis. J Biochem 2020;168:603-9. [PMID: 32653922 DOI: 10.1093/jb/mvaa074] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Liu CC, Wang YH, Chuang EY, Tsai MH, Chuang YH, Lin CL, Liu CJ, Hsiao BY, Lin SM, Liu LY. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers. Mol Carcinog. 2014;53:58-66. [PMID: 22911910 DOI: 10.1002/mc.21952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
202 Sánchez-Del Cojo M, López-Huertas MR, Díez-Fuertes F, Rodríguez-Mora S, Bermejo M, López-Campos G, Mateos E, Jiménez-Tormo L, Gómez-Esquer F, Díaz-Gil G, Alcamí J, Coiras M. Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells. PLoS One 2017;12:e0185677. [PMID: 28968466 DOI: 10.1371/journal.pone.0185677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
203 El Taghdouini A, van Grunsven LA. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis. Expert Rev Gastroenterol Hepatol 2016;10:1397-408. [PMID: 27762150 DOI: 10.1080/17474124.2016.1251309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
204 Wu SY, Wu AT, Yuan KS, Liu SH. Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells. J Cancer 2016;7:2408-19. [PMID: 27994679 DOI: 10.7150/jca.15703] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
205 Jourkesh M, Soori R, Earnest CP, Mirheidari L, Ravasi AA, Stannard SR, Monsalves-Alvarez M. Effects of six weeks of resistance-endurance training on microRNA-29 expression in the heart of ovariectomised rats. Prz Menopauzalny 2018;17:155-60. [PMID: 30766462 DOI: 10.5114/pm.2018.81737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
206 Shifeng H, Danni W, Pu C, Ping Y, Ju C, Liping Z. Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury. PLoS One 2013;8:e73133. [PMID: 24086271 DOI: 10.1371/journal.pone.0073133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
207 Özdirik B, Stueven AK, Mohr R, Geisler L, Wree A, Knorr J, Demir M, Vucur M, Loosen SH, Benz F, Reiss M, Wiedenmann B, Tacke F, Jann H, Hellberg T, Roderburg C. Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors-Results from an Exploratory Study. J Clin Med 2020;9:E2881. [PMID: 32899973 DOI: 10.3390/jcm9092881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
208 Wang Q, Du H, Li M, Li Y, Liu S, Gao P, Zhang X, Cheng J. MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet. Evid Based Complement Alternat Med 2013;2013:368103. [PMID: 23762126 DOI: 10.1155/2013/368103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
209 Li SC, Wang FS, Yang YL, Tiao MM, Chuang JH, Huang YH. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Int J Mol Sci 2016;17:324. [PMID: 26938532 DOI: 10.3390/ijms17030324] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
210 Gallant-Behm CL, Piper J, Lynch JM, Seto AG, Hong SJ, Mustoe TA, Maari C, Pestano LA, Dalby CM, Jackson AL, Rubin P, Marshall WS. A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin. J Invest Dermatol 2019;139:1073-81. [PMID: 30472058 DOI: 10.1016/j.jid.2018.11.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 19.7] [Reference Citation Analysis]
211 Hyun J, Jung Y. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling. World J Gastroenterol 2016; 22(29): 6652-6662 [PMID: 27547008 DOI: 10.3748/wjg.v22.i29.6652] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
212 Rajasekaran S, Rajaguru P, Sudhakar Gandhi PS. MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol 2015;6:254. [PMID: 26594173 DOI: 10.3389/fphar.2015.00254] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 10.2] [Reference Citation Analysis]
213 Roy S, Bantel H, Wandrer F, Schneider AT, Gautheron J, Vucur M, Tacke F, Trautwein C, Luedde T, Roderburg C. miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib. Journal of Hepatology 2017;67:966-78. [DOI: 10.1016/j.jhep.2017.06.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
214 Chang N, Duan X, Zhao Z, Tian L, Ji X, Yang L, Li L. Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury. J Cell Physiol 2020;235:2532-44. [PMID: 31495934 DOI: 10.1002/jcp.29157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
215 Ma L, Zhao J, Xie X. Sevoflurane induces liver injury by modulating the expression of insulin‐like growth factor 1 via miR‐214. J Cell Physiol 2018;233:6742-9. [DOI: 10.1002/jcp.26382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
216 Ren D, Li F, Gao A, Cao Q, Liu Y, Zhang J. Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29. Cell Cycle 2020;19:1067-76. [PMID: 32295500 DOI: 10.1080/15384101.2020.1731651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Zhao W, Cheng L, Quek C, Bellingham SA, Hill AF. Novel miR-29b target regulation patterns are revealed in two different cell lines. Sci Rep 2019;9:17449. [PMID: 31767948 DOI: 10.1038/s41598-019-53868-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Cheng N, Jin C, Jin P, Zhu D, Hou Z. High glucose protects cardiomyocytes against ischaemia/reperfusion injury by suppressing myocardiocyte apoptosis via circHIPK3/miR-29b/AKT3 signalling. J Cell Mol Med 2021. [PMID: 33951290 DOI: 10.1111/jcmm.16527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Hong JS, Lee DH, Yook YW, Na D, Jang YJ, Kim JH, Lee YS. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice. Biosci Biotechnol Biochem 2017;81:1348-55. [PMID: 28372490 DOI: 10.1080/09168451.2017.1308242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
220 Ouyang M, Su W, Xiao L, Rao JN, Jiang L, Li Y, Turner DJ, Gorospe M, Wang JY. Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation. Biochem J 2015;465:315-23. [PMID: 25317587 DOI: 10.1042/BJ20141028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
221 Zhang JJ, Yano H, Sasaki T, Matsuo N, Yoshioka H. The pro-α1(V) collagen gene (Col5a1) is coordinately regulated by miR-29b with core promoter in cultured cells. Connect Tissue Res 2018;59:263-73. [PMID: 28829698 DOI: 10.1080/03008207.2017.1370465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
222 Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830-41. [PMID: 25681399 DOI: 10.1136/gutjnl-2014-306842] [Cited by in Crossref: 485] [Cited by in F6Publishing: 463] [Article Influence: 80.8] [Reference Citation Analysis]
223 Aslani S, Sobhani S, Gharibdoost F, Jamshidi A, Mahmoudi M. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs. Hum Immunol 2018;79:178-87. [PMID: 29330110 DOI: 10.1016/j.humimm.2018.01.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
224 Xu XY, Du Y, Liu X, Ren Y, Dong Y, Xu HY, Shi JS, Jiang D, Xu X, Li L, Xu ZH, Geng Y. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice. Cell Commun Signal 2020;18:151. [PMID: 32933544 DOI: 10.1186/s12964-020-00610-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
225 An L, Lin Y, Li L, Kong M, Lou Y, Wu J, Liu Z. Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis. Front Pharmacol 2020;11:618262. [PMID: 33551818 DOI: 10.3389/fphar.2020.618262] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
226 Liu Q, Zhu Y, Zhu W, Zhang G, Yang YP, Zhao C. The role of MicroRNAs in tendon injury, repair, and related tissue engineering. Biomaterials 2021;277:121083. [PMID: 34488121 DOI: 10.1016/j.biomaterials.2021.121083] [Reference Citation Analysis]
227 Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge DC, Sun H, Wang H. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 2012;20:1222-33. [PMID: 22434133 DOI: 10.1038/mt.2012.35] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
228 Roderburg C, Mollnow T, Bongaerts B, Elfimova N, Vargas Cardenas D, Berger K, Zimmermann H, Koch A, Vucur M, Luedde M, Hellerbrand C, Odenthal M, Trautwein C, Tacke F, Luedde T. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One. 2012;7:e32999. [PMID: 22412969 DOI: 10.1371/journal.pone.0032999] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 7.7] [Reference Citation Analysis]
229 Bian EB, Huang C, Wang H, Chen XX, Tao H, Zhang L, Lv XW, Li J. The role of methyl-CpG binding protein 2 in liver fibrosis. Toxicology 2013;309:9-14. [PMID: 23619607 DOI: 10.1016/j.tox.2013.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
230 Ge Y, Xiao L, Chen X, Peng Y, Sun L, Liu F. MicroRNAs in peritoneal dialysis effluent are promising biomarkers for peritoneal fibrosis in peritoneal dialysis patients. Med Hypotheses 2012;78:155-6. [PMID: 22056978 DOI: 10.1016/j.mehy.2011.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
231 Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair. 2012;5:12. [PMID: 22849305 DOI: 10.1186/1755-1536-5-12] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
232 Yin R, Guo D, Zhang S, Zhang X. miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis. Sci Rep 2016;6:37509. [PMID: 27876854 DOI: 10.1038/srep37509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
233 Lambrecht J, Mannaerts I, van Grunsven LA. The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Front Physiol. 2015;6:209. [PMID: 26283969 DOI: 10.3389/fphys.2015.00209] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
234 Xue Y, Fan X, Yang R, Jiao Y, Li Y. miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS. Biosci Rep 2020;40:BSR20201227. [PMID: 32812641 DOI: 10.1042/BSR20201227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
235 Tang Y, Fan W, Zou B, Yan W, Hou Y, Kwabena Agyare O, Jiang Z, Qu S. TGF-β signaling and microRNA cross-talk regulates abdominal aortic aneurysm progression. Clin Chim Acta 2021;515:90-5. [PMID: 33388307 DOI: 10.1016/j.cca.2020.12.031] [Reference Citation Analysis]
236 Greuter T, Malhi H, Gores GJ, Shah VH. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017;2:95354. [PMID: 28878132 DOI: 10.1172/jci.insight.95354] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
237 Lew WY, Bayna E, Dalle Molle E, Contu R, Condorelli G, Tang T. Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice. PLoS One 2014;9:e107556. [PMID: 25233448 DOI: 10.1371/journal.pone.0107556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
238 Chen SR, Chen XP, Lu JJ, Wang Y, Wang YT. Potent natural products and herbal medicines for treating liver fibrosis. Chin Med. 2015;10:7. [PMID: 25897319 DOI: 10.1186/s13020-015-0036-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
239 Zheng QF, Zhang JY, Wu JS, Zhang Y, Liu M, Bai L, Zhang JY, Zhao J, Chen Y, Duan ZP, Zheng SJ. Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study. Medicine (Baltimore) 2016;95:e2639. [PMID: 26871786 DOI: 10.1097/MD.0000000000002639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
240 Tu X, Zheng X, Li H, Cao Z, Chang H, Luan S, Zhu J, Chen J, Zang Y, Zhang J. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells. Toxicol Sci. 2015;146:157-169. [PMID: 25912033 DOI: 10.1093/toxsci/kfv081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
241 Xu JY, Chen GH, Yang YJ. Exosomes: A Rising Star in Falling Hearts. Front Physiol 2017;8:494. [PMID: 28751864 DOI: 10.3389/fphys.2017.00494] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
242 Piperigkou Z, Götte M, Theocharis AD, Karamanos NK. Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing. Advanced Drug Delivery Reviews 2018;129:16-36. [DOI: 10.1016/j.addr.2017.10.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
243 Zhou LY, Lin SN, Rieder F, Chen MH, Zhang SH, Mao R. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside. Inflamm Bowel Dis 2021;27:971-82. [PMID: 33324986 DOI: 10.1093/ibd/izaa321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Loosen SH, Lurje G, Wiltberger G, Vucur M, Koch A, Kather JN, Paffenholz P, Tacke F, Ulmer FT, Trautwein C, Luedde T, Neumann UP, Roderburg C. Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLoS One. 2019;14:e0210944. [PMID: 30653586 DOI: 10.1371/journal.pone.0210944] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
245 Tacke F, Spehlmann ME, Vucur M, Benz F, Luedde M, Cardenas DV, Roy S, Loosen S, Hippe HJ, Frey N, Trautwein C, Koch A, Roderburg C, Luedde T. miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years. Mediators Inflamm 2019;2019:6714080. [PMID: 30918471 DOI: 10.1155/2019/6714080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
246 Musaddaq G, Shahzad N, Ashraf MA, Arshad MI. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human. Biomarkers 2019;24:103-9. [PMID: 30252499 DOI: 10.1080/1354750X.2018.1528631] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
247 You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, Yuan Y, Yang J, Zhuang SM. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids. 2018;12:57-66. [PMID: 30195793 DOI: 10.1016/j.omtn.2018.04.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
248 Kwiecinski M, Noetel A, Elfimova N, Trebicka J, Schievenbusch S, Strack I, Molnar L, von Brandenstein M, Töx U, Nischt R. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One. 2011;6:e24568. [PMID: 21931759 DOI: 10.1371/journal.pone.0024568] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
249 Yang Z, Cappello T, Wang L. Emerging role of microRNAs in lipid metabolism. Acta Pharm Sin B 2015;5:145-50. [PMID: 26579440 DOI: 10.1016/j.apsb.2015.01.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 15.0] [Reference Citation Analysis]
250 Wu J, Huang J, Kuang S, Chen J, Li X, Chen B, Wang J, Cheng D, Shuai X. Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells. Adv Sci (Weinh) 2019;6:1801809. [PMID: 30886803 DOI: 10.1002/advs.201801809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
251 McDonough JE, Ahangari F, Li Q, Jain S, Verleden SE, Herazo-Maya J, Vukmirovic M, DeIuliis G, Tzouvelekis A, Tanabe N, Chu F, Yan X, Verschakelen J, Homer RJ, Manatakis DV, Zhang J, Ding J, Maes K, De Sadeleer L, Vos R, Neyrinck A, Benos PV, Bar-Joseph Z, Tantin D, Hogg JC, Vanaudenaerde BM, Wuyts WA, Kaminski N. Transcriptional regulatory model of fibrosis progression in the human lung. JCI Insight 2019;4:131597. [PMID: 31600171 DOI: 10.1172/jci.insight.131597] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
252 Yu K, Shi G, Li N. The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright. Annals of Hepatology 2015;14:450-6. [DOI: 10.1016/s1665-2681(19)31165-2] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
253 Kim KH, Park KK. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol 2014; 20(40): 14696-14705 [PMID: 25356032 DOI: 10.3748/wjg.v20.i40.14696] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
254 Friedman SL. Focus. J Hepatol 2012;56:1-3. [PMID: 21906568 DOI: 10.1016/j.jhep.2011.08.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
255 Moore CC, Mckillop IH, Huynh T. MicroRNA expression following activated protein C treatment during septic shock. Journal of Surgical Research 2013;182:116-26. [DOI: 10.1016/j.jss.2012.07.063] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
256 Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, Trautwein C, Luedde T. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med 2014;42:1096-104. [PMID: 24413579 DOI: 10.1097/CCM.0000000000000131] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
257 Najafi A, Motaghi E, Hosseini MJ, Ghasemi-pirbaluti M. The effect of sodium valproate on acetic acid-induced colitis in rats. Inflammopharmacol 2017;25:137-45. [DOI: 10.1007/s10787-016-0304-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
258 Xu Y, Niu Y, Wu B, Cao X, Gong T, Zhang ZR, Fu Y. Extended-release of therapeutic microRNA via a host-guest supramolecular hydrogel to locally alleviate renal interstitial fibrosis. Biomaterials 2021;275:120902. [PMID: 34087588 DOI: 10.1016/j.biomaterials.2021.120902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Han Z, Zhang T, He Y, Li G, Li G, Jin X. Inhibition of prostaglandin E2 protects abdominal aortic aneurysm from expansion through regulating miR-29b-mediated fibrotic ECM expression. Exp Ther Med 2018;16:155-60. [PMID: 29896234 DOI: 10.3892/etm.2018.6160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
260 Hand NJ, Horner AM, Master ZR, Boateng LA, LeGuen C, Uvaydova M, Friedman JR. MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia. J Pediatr Gastroenterol Nutr 2012;54:186-92. [PMID: 22167021 DOI: 10.1097/MPG.0b013e318244148b] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
261 Wang Z, Zhao Y, Zhao H, Zhou J, Feng D, Tang F, Li Y, Lv L, Chen Z, Ma X, Tian X, Yao J. Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression. Mol Ther Nucleic Acids 2020;21:751-63. [PMID: 32781430 DOI: 10.1016/j.omtn.2020.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
262 Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol. 2012;3:49. [PMID: 22457651 DOI: 10.3389/fphys.2012.00049] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 10.4] [Reference Citation Analysis]
263 O'Hara SP, Gradilone SA, Masyuk TV, Tabibian JH, LaRusso NF. MicroRNAs in Cholangiopathies. Curr Pathobiol Rep 2014;2:133-42. [PMID: 25097819 DOI: 10.1007/s40139-014-0048-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
264 Harmanci D, Erkan EP, Kocak A, Akdogan GG. Role of the microRNA-29 family in fibrotic skin diseases. Biomed Rep 2017;6:599-604. [PMID: 28584629 DOI: 10.3892/br.2017.900] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
265 Li YS, Ni SY, Meng Y, Shi XL, Zhao XW, Luo HH, Li X. Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II. PLoS One. 2013;8:e76289. [PMID: 24155898 DOI: 10.1371/journal.pone.0076289] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
266 Kitano M, Bloomston PM. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. J Clin Med. 2016;5. [PMID: 26999230 DOI: 10.3390/jcm5030038] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
267 Deng X, Chu X, Wang P, Ma X, Wei C, Sun C, Yang J, Li Y. MicroRNA-29a-3p Reduces TNFα-Induced Endothelial Dysfunction by Targeting Tumor Necrosis Factor Receptor 1. Mol Ther Nucleic Acids 2019;18:903-15. [PMID: 31760375 DOI: 10.1016/j.omtn.2019.10.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
268 Vyas HS, Upadhyay KK, Devkar RV. miRNAs Signatures In Patients With Acute Liver Injury: Clinical Concerns and Correlations. Curr Mol Med 2020;20:325-35. [PMID: 31823701 DOI: 10.2174/1566524020666191211153546] [Reference Citation Analysis]
269 Nijhuis A, Biancheri P, Lewis A, Bishop CL, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A, Corazza GR. In Crohn’s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clin Sci (Lond). 2014;127:341-350. [PMID: 24641356 DOI: 10.1042/cs20140048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 7.7] [Reference Citation Analysis]
270 Rountree CB, Mishra L, Willenbring H. Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology. 2012;55:298-306. [PMID: 22030746 DOI: 10.1002/hep.24762] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
271 Lin HY, Wang FS, Yang YL, Huang YH. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Cells 2019;8:E1298. [PMID: 31652636 DOI: 10.3390/cells8101298] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
272 Duan B, Hu J, Zhang T, Luo X, Zhou Y, Liu S, Zhu L, Wu C, Liu W, Chen C, Gao H. miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation. BMC Gastroenterol 2017;17:12. [PMID: 28095789 DOI: 10.1186/s12876-017-0571-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
273 Hardy T, Mann DA. Epigenetics in liver disease: from biology to therapeutics. Gut. 2016;65:1895-1905. [PMID: 27624887 DOI: 10.1136/gutjnl-2015-311292] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 15.4] [Reference Citation Analysis]
274 Kwiecinski M, Elfimova N, Noetel A, Töx U, Steffen HM, Hacker U, Nischt R, Dienes HP, Odenthal M. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab Invest. 2012;92:978-987. [PMID: 22565577 DOI: 10.1038/labinvest.2012.70] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
275 Huang YH, Tiao MM, Huang LT, Chuang JH, Kuo KC, Yang YL, Wang FS. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. PLoS One. 2015;10:e0136453. [PMID: 26305546 DOI: 10.1371/journal.pone.0136453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
276 Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW, Bonkovsky HL, Schrum LW. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology. 2012;56:300-310. [PMID: 22278637 DOI: 10.1002/hep.25613] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 14.6] [Reference Citation Analysis]
277 Li ZJ, Ou-Yang PH, Han XP. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal. 2014;26:141-148. [PMID: 24100264 DOI: 10.1016/j.cellsig.2013.09.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
278 Xin L, Gao J, Wang D, Lin JH, Liao Z, Ji JT, Du TT, Jiang F, Hu LH, Li ZS. Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis. Sci Rep. 2017;7:40019. [PMID: 28074846 DOI: 10.1038/srep40019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
279 Dkhil MA, Al-Quraishy SA, Abdel-Baki AS, Delic D, Wunderlich F. Differential miRNA Expression in the Liver of Balb/c Mice Protected by Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria. Front Microbiol 2016;7:2155. [PMID: 28123381 DOI: 10.3389/fmicb.2016.02155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
280 Zhu S, Wang T, Luo F, Li H, Jia Q, He T, Wu H, Zou T. Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway. Mol Med Rep 2019;19:3537-47. [PMID: 30896849 DOI: 10.3892/mmr.2019.10025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
281 Li H, Jiang JD, Peng ZG. MicroRNA-mediated interactions between host and hepatitis C virus. World J Gastroenterol 2016; 22(4): 1487-1496 [PMID: 26819516 DOI: 10.3748/wjg.v22.i4.1487] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
282 Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 178] [Article Influence: 28.9] [Reference Citation Analysis]
283 Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016;96:1297-1325. [PMID: 27535639 DOI: 10.1152/physrev.00041.2015] [Cited by in Crossref: 668] [Cited by in F6Publishing: 695] [Article Influence: 167.0] [Reference Citation Analysis]
284 Wang H, Li C, Jian Z, Ou Y, Ou J. TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4. PLoS One 2015;10:e0136703. [PMID: 26441331 DOI: 10.1371/journal.pone.0136703] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
285 Ezhilarasan D. MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 2020;885:173507. [PMID: 32858048 DOI: 10.1016/j.ejphar.2020.173507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
286 Tzouvelekis A, Kaminski N. Epigenetics in idiopathic pulmonary fibrosis. Biochem Cell Biol 2015;93:159-70. [PMID: 25659821 DOI: 10.1139/bcb-2014-0126] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
287 Kim KM, Kim SG. Autophagy and microRNA dysregulation in liver diseases. Arch Pharm Res 2014;37:1097-116. [PMID: 25015129 DOI: 10.1007/s12272-014-0439-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
288 Talasila A, Yu H, Ackers-Johnson M, Bot M, van Berkel T, Bennett MR, Bot I, Sinha S. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β. Arterioscler Thromb Vasc Biol 2013;33:2355-65. [PMID: 23825366 DOI: 10.1161/ATVBAHA.112.301000] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
289 Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med. 2012;16:2647-2654. [PMID: 22469499 DOI: 10.1111/j.1582-4934.2012.01578.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
290 Hsu CH, Liu IF, Kuo HF, Li CY, Lian WS, Chang CY, Chen YH, Liu WL, Lu CY, Liu YR, Lin TC, Lee TY, Huang CY, Hsieh CC, Liu PL. miR-29a-3p/THBS2 Axis Regulates PAH-Induced Cardiac Fibrosis. Int J Mol Sci 2021;22:10574. [PMID: 34638915 DOI: 10.3390/ijms221910574] [Reference Citation Analysis]
291 Timóteo-Ferreira F, Mendes S, Rocha NA, Matos L, Rodrigues AR, Almeida H, Silva E. Apocynin Dietary Supplementation Delays Mouse Ovarian Ageing. Oxid Med Cell Longev 2019;2019:5316984. [PMID: 31772706 DOI: 10.1155/2019/5316984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
292 Mullenbrock S, Liu F, Szak S, Hronowski X, Gao B, Juhasz P, Sun C, Liu M, McLaughlin H, Xiao Q, Feghali-Bostwick C, Zheng TS. Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts. Genes (Basel) 2018;9:E588. [PMID: 30501089 DOI: 10.3390/genes9120588] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
293 Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. PLoS One 2015;10:e0124411. [PMID: 25923107 DOI: 10.1371/journal.pone.0124411] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
294 Teng KY, Ghoshal K. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis. Gene Expr 2015;16:155-62. [PMID: 26637395 DOI: 10.3727/105221615X14399878166078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
295 Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Ther Targets. 2014;18:1011-1021. [PMID: 24935558 DOI: 10.1517/14728222.2014.927443] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
296 Sarkar N, Chakravarty R. Hepatitis B Virus Infection, MicroRNAs and Liver Disease. Int J Mol Sci. 2015;16:17746-17762. [PMID: 26247932 DOI: 10.3390/ijms160817746] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
297 Cao Q, Deji QZ, Liu YJ, Ye W, Zhaba WD, Jiang Q, Yan F. The role of mechanical stretch and TGF-β2 in epithelial-mesenchymal transition of retinal pigment epithelial cells. Int J Ophthalmol 2019;12:1832-8. [PMID: 31850164 DOI: 10.18240/ijo.2019.12.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
298 Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028-1040. [PMID: 22772564 DOI: 10.1038/nm.2807] [Cited by in Crossref: 1669] [Cited by in F6Publishing: 1604] [Article Influence: 185.4] [Reference Citation Analysis]
299 Riaz F, Li D. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Curr Gene Ther 2019;19:305-17. [PMID: 31696817 DOI: 10.2174/1566523219666191107113046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
300 Roy S, Trautwein C, Luedde T, Roderburg C. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Front Pharmacol 2018;9:805. [PMID: 30158867 DOI: 10.3389/fphar.2018.00805] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
301 Jiang XP, Ai WB, Wan LY, Zhang YQ, Wu JF. The roles of microRNA families in hepatic fibrosis. Cell Biosci. 2017;7:34. [PMID: 28680559 DOI: 10.1186/s13578-017-0161-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
302 Jiang B, Huo Y, Gu Y, Wang J. The role of microRNAs in myopia. Graefes Arch Clin Exp Ophthalmol 2017;255:7-13. [PMID: 27837278 DOI: 10.1007/s00417-016-3532-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
303 Chen Y, Verfaillie CM. MicroRNAs: the fine modulators of liver development and function. Liver Int. 2014;34:976-990. [PMID: 24517588 DOI: 10.1111/liv.12496] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
304 Huang J, Yu X, Fries JW, Zhang L, Odenthal M. MicroRNA function in the profibrogenic interplay upon chronic liver disease. Int J Mol Sci 2014;15:9360-71. [PMID: 24871365 DOI: 10.3390/ijms15069360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
305 Huang YH, Kuo HC, Yang YL, Wang FS. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Int J Med Sci 2019;16:212-20. [PMID: 30745801 DOI: 10.7150/ijms.29930] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
306 Liu MX, Gao M, Li CZ, Yu CZ, Yan H, Peng C, Li Y, Li CG, Ma ZL, Zhao Y. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. Acta Pharmacol Sin. 2017;38:660-671. [PMID: 28112179 DOI: 10.1038/aps.2016.158] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
307 Tai Y, Zhao C, Gao J, Lan T, Tong H. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. PeerJ 2021;9:e11910. [PMID: 34434654 DOI: 10.7717/peerj.11910] [Reference Citation Analysis]
308 Yi S, Qin X, Luo X, Zhang Y, Liu Z, Zhu L. Identification of miRNAs associated with the mechanical response of hepatic stellate cells by miRNA microarray analysis. Exp Ther Med 2018;16:1707-14. [PMID: 30186391 DOI: 10.3892/etm.2018.6384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
309 Rius B, Titos E, Morán‐salvador E, López‐vicario C, García‐alonso V, González‐périz A, Arroyo V, Claria J. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis. FASEB j 2013;28:836-48. [DOI: 10.1096/fj.13-235614] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
310 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
311 Luo X, Zhang D, Xie J, Su Q, He X, Bai R, Gao G, Pan W. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7. Mol Ther Methods Clin Dev 2018;11:73-82. [PMID: 30406154 DOI: 10.1016/j.omtm.2018.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
312 Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, Cooper ME, Kantharidis P. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012;23:252-65. [PMID: 22095944 DOI: 10.1681/ASN.2011010055] [Cited by in Crossref: 331] [Cited by in F6Publishing: 182] [Article Influence: 33.1] [Reference Citation Analysis]
313 Uemura R, Murakami Y, Hashimoto A, Sawada A, Otani K, Taira K, Hosomi S, Nagami Y, Tanaka F, Kamata N, Yamagami H, Tanigawa T, Watanabe T, Taguchi YH, Fujiwara Y. Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis. Int J Mol Sci 2017;18:E1611. [PMID: 28757556 DOI: 10.3390/ijms18081611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
314 Roderburg C, Trautwein C. Cell-specific functions of miRNA in the liver. J Hepatol 2017;66:655-6. [PMID: 27702640 DOI: 10.1016/j.jhep.2016.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
315 Oksuz Z, Serin MS, Kaplan E, Dogen A, Tezcan S, Aslan G, Emekdas G, Sezgin O, Altintas E, Tiftik EN. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 2015;42:713-720. [PMID: 25391771 DOI: 10.1007/s11033-014-3819-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
316 Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919-1929. [PMID: 30783469 DOI: 10.3892/etm.2018.7117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
317 Sadri Nahand J, Shojaie L, Akhlagh SA, Ebrahimi MS, Mirzaei HR, Bannazadeh Baghi H, Mahjoubin-Tehran M, Rezaei N, Hamblin MR, Tajiknia V, Rahimian N, Mirzaei H. Cell death pathways and viruses: Role of microRNAs. Mol Ther Nucleic Acids 2021;24:487-511. [PMID: 33898103 DOI: 10.1016/j.omtn.2021.03.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
318 Matsuda M, Seki E. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. Semin Liver Dis 2020;40:307-20. [PMID: 32242330 DOI: 10.1055/s-0040-1708876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
319 Ciechomska M, van Laar JM, O'reilly S. Emerging role of epigenetics in systemic sclerosis pathogenesis. Genes Immun 2014;15:433-9. [DOI: 10.1038/gene.2014.44] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
320 Scian MJ, Maluf DG, Mas VR. MiRNAs in kidney transplantation: potential role as new biomarkers. Expert Review of Molecular Diagnostics 2014;13:93-104. [DOI: 10.1586/erm.12.131] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
321 Tan W, Li Y, Lim SG, Tan TM. miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5962-5972 [PMID: 24876719 DOI: 10.3748/wjg.v20.i20.5962] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
322 Yuan Y, Han Q, Li S, Tian Z, Zhang J. Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling. Sci Rep 2017;7:3952. [PMID: 28638086 DOI: 10.1038/s41598-017-04374-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
323 Tao L, Xue D, Shen D, Ma W, Zhang J, Wang X, Zhang W, Wu L, Pan K, Yang Y, Nwosu ZC, Dooley S, Seki E, Liu C. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis. Arch Toxicol 2018;92:2935-46. [PMID: 30097701 DOI: 10.1007/s00204-018-2278-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
324 Xue H, Zhang G, Geurts AM, Usa K, Jensen DM, Liu Y, Widlansky ME, Liang M. Tissue-specific effects of targeted mutation of Mir29b1 in rats. EBioMedicine 2018;35:260-9. [PMID: 30120082 DOI: 10.1016/j.ebiom.2018.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
325 Wu L, Sun J, Su X, Yu Q, Yu Q, Zhang P. A review about the development of fucoidan in antitumor activity: Progress and challenges. Carbohydr Polym 2016;154:96-111. [PMID: 27577901 DOI: 10.1016/j.carbpol.2016.08.005] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 22.0] [Reference Citation Analysis]
326 毕艺鸣, 许嘉彬, 安海燕. MicroRNAs对HSC生物学功能的影响. 世界华人消化杂志 2014; 22(24): 3587-3591 [DOI: 10.11569/wcjd.v22.i24.3587] [Reference Citation Analysis]
327 Yang L, Engeland CG, Cheng B. Social isolation impairs oral palatal wound healing in sprague-dawley rats: a role for miR-29 and miR-203 via VEGF suppression. PLoS One 2013;8:e72359. [PMID: 23951316 DOI: 10.1371/journal.pone.0072359] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
328 Monaghan M, Browne S, Schenke-Layland K, Pandit A. A collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodeling. Mol Ther 2014;22:786-96. [PMID: 24402185 DOI: 10.1038/mt.2013.288] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 10.0] [Reference Citation Analysis]
329 Kawada N. Evolution of hepatic fibrosis research. Hepatol Res. 2011;41:199-208. [PMID: 21338451 DOI: 10.1111/j.1872-034x.2011.00776.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
330 Monaghan MG, Holeiter M, Brauchle E, Layland SL, Lu Y, Deb A, Pandit A, Nsair A, Schenke-Layland K. Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium. Tissue Eng Part A 2018;24:57-67. [PMID: 28463641 DOI: 10.1089/ten.TEA.2016.0527] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
331 Tu X, Zhang Y, Zheng X, Deng J, Li H, Kang Z, Cao Z, Huang Z, Ding Z, Dong L, Chen J, Zang Y, Zhang J. TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice. Sci Rep 2017;7:2957. [PMID: 28592847 DOI: 10.1038/s41598-017-03175-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
332 Schlabritz-Loutsevitch N, Apostolakis-Kyrus K, Krutilina R, Hubbard G, Kocak M, Janjetovic Z, Sathanandam S, Slominski AT, Mari G, Dick E Jr. Pregnancy-driven cardiovascular maternal miR-29 plasticity in obesity. J Med Primatol 2016;45:297-303. [PMID: 27627870 DOI: 10.1111/jmp.12236] [Reference Citation Analysis]
333 Farid WR, Verhoeven CJ, de Jonge J, Metselaar HJ, Kazemier G, van der Laan LJ. The ins and outs of microRNAs as biomarkers in liver disease and transplantation. Transpl Int 2014;27:1222-32. [PMID: 24963540 DOI: 10.1111/tri.12379] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
334 Calabro NE, Barrett A, Chamorro-Jorganes A, Tam S, Kristofik NJ, Xing H, Loye AM, Sessa WC, Hansen K, Kyriakides TR. Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29. Matrix Biol 2019;82:71-85. [PMID: 30876926 DOI: 10.1016/j.matbio.2019.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
335 Boon RA, Dimmeler S. MicroRNAs and Aneurysm Formation. Trends in Cardiovascular Medicine 2011;21:172-7. [DOI: 10.1016/j.tcm.2012.05.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
336 Riedel L, Fischer B, Ly TD, Hendig D, Kuhn J, Knabbe C, Faust I. microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway. Sci Rep 2018;8:17779. [PMID: 30542210 DOI: 10.1038/s41598-018-36217-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
337 Chen YJ, Zhu JM, Wu H, Fan J, Zhou J, Hu J, Yu Q, Liu TT, Yang L, Wu CL, Guo XL, Huang XW, Shen XZ. Circulating microRNAs as a Fingerprint for Liver Cirrhosis. PLoS One. 2013;8:e66577. [PMID: 23805240 DOI: 10.1371/journal.pone.0066577] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
338 Creemers EE, van Rooij E. Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis. Circ Res 2016;118:108-18. [PMID: 26538569 DOI: 10.1161/CIRCRESAHA.115.305242] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
339 Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. Mol Ther. 2016;24:1848-1859. [PMID: 27480597 DOI: 10.1038/mt.2016.127] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
340 Castoldi G, di Gioia C, Giollo F, Carletti R, Bombardi C, Antoniotti M, Roma F, Zerbini G, Stella A. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis. Clin Exp Pharmacol Physiol 2016;43:335-42. [PMID: 26700017 DOI: 10.1111/1440-1681.12532] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
341 He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. The potential of microRNAs in liver fibrosis. Cell Signal. 2012;24:2268-2272. [PMID: 22884954 DOI: 10.1016/j.cellsig.2012.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 9.2] [Reference Citation Analysis]
342 Seki E, Brenner DA. Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci. 2015;22:512-518. [PMID: 25869468 DOI: 10.1002/jhbp.245] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 22.8] [Reference Citation Analysis]
343 Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM, Liu HM, He J, Yu HY, Zhu L. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J. 2011;278:1522-1532. [PMID: 21366874 DOI: 10.1111/j.1742-4658.2011.08075.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
344 Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 22.4] [Reference Citation Analysis]
345 Li H, Ge Q, Guo L, Lu Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int 2013;2013:970265. [PMID: 24195082 DOI: 10.1155/2013/970265] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
346 Bhattacharyya S, Kelley K, Melichian DS, Tamaki Z, Fang F, Su Y, Feng G, Pope RM, Budinger GR, Mutlu GM, Lafyatis R, Radstake T, Feghali-Bostwick C, Varga J. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 2013;182:192-205. [PMID: 23141927 DOI: 10.1016/j.ajpath.2012.09.007] [Cited by in Crossref: 160] [Cited by in F6Publishing: 159] [Article Influence: 17.8] [Reference Citation Analysis]
347 Yang X, Liang Y, Bamunuarachchi G, Xu Y, Vaddadi K, Pushparaj S, Xu D, Zhu Z, Blaha R, Huang C, Liu L. miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor. Arch Virol 2021;166:363-73. [PMID: 33206218 DOI: 10.1007/s00705-020-04877-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
348 Yao K, Ricardo SD. Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease. Nephrology (Carlton) 2016;21:363-71. [PMID: 26437381 DOI: 10.1111/nep.12643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
349 Chung AC, Yu X, Lan HY. MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis. 2013;6:169-179. [PMID: 24109192 DOI: 10.2147/ijnrd.s37885] [Cited by in Crossref: 11] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
350 Lambrecht J, Verhulst S, Reynaert H, van Grunsven LA. The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. Cells 2019;8:E1003. [PMID: 31470644 DOI: 10.3390/cells8091003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
351 Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ 2014;5:3. [PMID: 24484532 DOI: 10.1186/2042-6410-5-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 14.0] [Reference Citation Analysis]
352 Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028-1040. [PMID: 22772564 DOI: 10.1038/nm.2807)] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 McDermott AM, Heneghan HM, Miller N, Kerin MJ. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm Res 2011;28:3016-29. [PMID: 21818713 DOI: 10.1007/s11095-011-0550-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
354 Peng WJ, Tao JH, Mei B, Chen B, Li BZ, Yang GJ, Zhang Q, Yao H, Wang BX, He Q, Wang J. MicroRNA-29: a potential therapeutic target for systemic sclerosis. Expert Opin Ther Targets 2012;16:875-9. [PMID: 22793265 DOI: 10.1517/14728222.2012.708339] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
355 Guldiken N, Kobazi Ensari G, Lahiri P, Couchy G, Preisinger C, Liedtke C, Zimmermann HW, Ziol M, Boor P, Zucman-Rossi J, Trautwein C, Strnad P. Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease. J Hepatol 2016;65:552-9. [PMID: 27151178 DOI: 10.1016/j.jhep.2016.04.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
356 Kumarswamy R, Volkmann I, Jazbutyte V, Dangwal S, Park DH, Thum T. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arterioscler Thromb Vasc Biol. 2012;32:361-369. [PMID: 22095988 DOI: 10.1161/atvbaha.111.234286] [Cited by in Crossref: 204] [Cited by in F6Publishing: 122] [Article Influence: 20.4] [Reference Citation Analysis]
357 Ge S, Xie J, Liu F, He J, He J. MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol. J Cell Biochem 2015;116:2455-64. [PMID: 25650006 DOI: 10.1002/jcb.25116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
358 Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011;71:7670-82. [PMID: 21987723 DOI: 10.1158/0008-5472.CAN-11-0964] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 10.7] [Reference Citation Analysis]
359 Ben-Moshe S, Shapira Y, Moor AE, Manco R, Veg T, Bahar Halpern K, Itzkovitz S. Spatial sorting enables comprehensive characterization of liver zonation. Nat Metab 2019;1:899-911. [PMID: 31535084 DOI: 10.1038/s42255-019-0109-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 17.5] [Reference Citation Analysis]
360 Zhang Y, Ghazwani M, Li J, Sun M, Stolz DB, He F, Fan J, Xie W, Li S. MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase. Biochem Biophys Res Commun. 2014;446:940-944. [PMID: 24650661 DOI: 10.1016/j.bbrc.2014.03.037] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
361 Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4:391-417. [PMID: 22043231 DOI: 10.1177/1756283x11413002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 71] [Article Influence: 14.1] [Reference Citation Analysis]
362 Mizuno K, Seki N, Mataki H, Matsushita R, Kamikawaji K, Kumamoto T, Takagi K, Goto Y, Nishikawa R, Kato M, Enokida H, Nakagawa M, Inoue H. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma. Int J Oncol 2016;48:450-60. [PMID: 26676674 DOI: 10.3892/ijo.2015.3289] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
363 Loosen SH, Schueller F, Trautwein C, Roy S, Roderburg C. Role of circulating microRNAs in liver diseases. World J Hepatol 2017; 9(12): 586-594 [PMID: 28515844 DOI: 10.4254/wjh.v9.i12.586] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
364 Kinoshita T, Nohata N, Hanazawa T, Kikkawa N, Yamamoto N, Yoshino H, Itesako T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Br J Cancer 2013;109:2636-45. [PMID: 24091622 DOI: 10.1038/bjc.2013.607] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 10.6] [Reference Citation Analysis]
365 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
366 Silva GJ, Bye A, el Azzouzi H, Wisløff U. MicroRNAs as Important Regulators of Exercise Adaptation. Progress in Cardiovascular Diseases 2017;60:130-51. [DOI: 10.1016/j.pcad.2017.06.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 15.8] [Reference Citation Analysis]
367 Shah N, Nelson JE, Kowdley KV. MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol. 2013;3:231-242. [PMID: 25755505 DOI: 10.1016/j.jceh.2013.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
368 Cai P, Piao X, Liu S, Hou N, Wang H, Chen Q. MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection. PLoS One 2013;8:e67037. [PMID: 23825609 DOI: 10.1371/journal.pone.0067037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
369 Fiserova B, Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. The miR-29 family in hematological malignancies. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:184-91. [PMID: 25004911 DOI: 10.5507/bp.2014.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
370 He Y, Huang C, Lin X, Li J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie. 2013;95:1355-1359. [PMID: 23542596 DOI: 10.1016/j.biochi.2013.03.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 13.5] [Reference Citation Analysis]
371 Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int. 2014;2014:741465. [PMID: 24745023 DOI: 10.1155/2014/741465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
372 Markovic J, Sharma AD, Balakrishnan A. MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury. Cells 2020;9:E1767. [PMID: 32717951 DOI: 10.3390/cells9081767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
373 Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY. MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis. Lab Invest 2014;94:978-90. [PMID: 25046436 DOI: 10.1038/labinvest.2014.91] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
374 Ramamoorthy A, Liu Y, Philips S, Desta Z, Lin H, Goswami C, Gaedigk A, Li L, Flockhart DA, Skaar TC. Regulation of microRNA expression by rifampin in human hepatocytes. Drug Metab Dispos 2013;41:1763-8. [PMID: 23935064 DOI: 10.1124/dmd.113.052886] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
375 Ma L, Ma J, Ou HL. MicroRNA‑219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor β receptor 2. Mol Med Rep 2019;19:1543-50. [PMID: 30592264 DOI: 10.3892/mmr.2018.9787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
376 Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ, Kim SG. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology. 2012;142:1206-1217.e7. [PMID: 22265968 DOI: 10.1053/j.gastro.2012.01.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
377 Sinigaglia A, Lavezzo E, Trevisan M, Sanavia T, Di Camillo B, Peta E, Scarpa M, Castagliuolo I, Guido M, Sarcognato S, Cappellesso R, Fassina A, Cardin R, Farinati F, Palù G, Barzon L. Changes in microRNA expression during disease progression in patients with chronic viral hepatitis. Liver Int 2015;35:1324-33. [PMID: 25417901 DOI: 10.1111/liv.12737] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
378 Huleihel L, Ben-Yehudah A, Milosevic J, Yu G, Pandit K, Sakamoto K, Yousef H, LeJeune M, Coon TA, Redinger CJ, Chensny L, Manor E, Schatten G, Kaminski N. Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2014;306:L534-42. [PMID: 24441869 DOI: 10.1152/ajplung.00149.2013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
379 Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 2012;44:237-44. [PMID: 22214600 DOI: 10.1152/physiolgenomics.00141.2011] [Cited by in Crossref: 296] [Cited by in F6Publishing: 298] [Article Influence: 32.9] [Reference Citation Analysis]
380 Weigel C, Schmezer P, Plass C, Popanda O. Epigenetics in radiation-induced fibrosis. Oncogene. 2015;34:2145-2155. [PMID: 24909163 DOI: 10.1038/onc.2014.145] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
381 Schon HT, Bartneck M, Borkham-Kamphorst E, Nattermann J, Lammers T, Tacke F, Weiskirchen R. Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis. Front Pharmacol 2016;7:33. [PMID: 26941644 DOI: 10.3389/fphar.2016.00033] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
382 Sen CK, Ghatak S. miRNA control of tissue repair and regeneration. Am J Pathol 2015;185:2629-40. [PMID: 26056933 DOI: 10.1016/j.ajpath.2015.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
383 Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis: MicroRNAs, TGF-β1, and tissue fibrosis. J Pathol 2013;229:274-85. [DOI: 10.1002/path.4119] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 13.4] [Reference Citation Analysis]
384 Tang PM, Lan H. MicroRNAs in TGF-β/Smad-mediated Tissue Fibrosis. Curr Pathobiol Rep 2014;2:235-43. [DOI: 10.1007/s40139-014-0060-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
385 Cheng R, Xu H, Hong Y. miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2. Mol Med Rep 2021;24:777. [PMID: 34498712 DOI: 10.3892/mmr.2021.12417] [Reference Citation Analysis]
386 Ni H, Li W, Zhuge Y, Xu S, Wang Y, Chen Y, Shen G, Wang F. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Int J Cardiol 2019;292:188-96. [PMID: 30967276 DOI: 10.1016/j.ijcard.2019.04.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 26.5] [Reference Citation Analysis]
387 Lewis A, Nijhuis A, Mehta S, Kumagai T, Feakins R, Lindsay JO, Silver A. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets. Inflamm Bowel Dis 2015;21:1141-50. [PMID: 25636122 DOI: 10.1097/MIB.0000000000000298] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
388 Yano H, Hamanaka R, Zhang JJ, Yano M, Hida M, Matsuo N, Yoshioka H. MicroRNA-26 regulates the expression of CTGF after exposure to ionizing radiation. Radiat Environ Biophys 2021;60:411-9. [PMID: 33959794 DOI: 10.1007/s00411-021-00915-9] [Reference Citation Analysis]
389 Yamaura Y, Tatsumi N, Takagi S, Tokumitsu S, Fukami T, Tajiri K, Minemura M, Yokoi T, Nakajima M. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury. Clin Biochem. 2017;50:1034-1039. [PMID: 28823616 DOI: 10.1016/j.clinbiochem.2017.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
390 Yamada Y, Takanashi M, Sudo K, Ueda S, Ohno SI, Kuroda M. Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis. PLoS One 2017;12:e0171957. [PMID: 28234907 DOI: 10.1371/journal.pone.0171957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
391 Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 154] [Article Influence: 24.7] [Reference Citation Analysis]
392 Jafarinejad-farsangi S, Gharibdoost F, Farazmand A, Kavosi H, Jamshidi A, Karimizadeh E, Noorbakhsh F, Mahmoudi M. MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 2019;52:108-16. [DOI: 10.1080/08916934.2019.1621856] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
393 Hysolli E, Tanaka Y, Su J, Kim KY, Zhong T, Janknecht R, Zhou XL, Geng L, Qiu C, Pan X, Jung YW, Cheng J, Lu J, Zhong M, Weissman SM, Park IH. Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family. Stem Cell Reports 2016;7:43-54. [PMID: 27373925 DOI: 10.1016/j.stemcr.2016.05.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
394 Szabo G, Sarnow P, Bala S. MicroRNA silencing and the development of novel therapies for liver disease. J Hepatol 2012;57:462-6. [PMID: 22504335 DOI: 10.1016/j.jhep.2012.01.030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
395 Ponticos M, Smith BD. Extracellular matrix synthesis in vascular disease: hypertension, and atherosclerosis. J Biomed Res 2014;28:25-39. [PMID: 24474961 DOI: 10.7555/JBR.27.20130064] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
396 Huang H, Huang X, Luo S, Zhang H, Hu F, Chen R, Huang C, Su Z. The MicroRNA MiR-29c Alleviates Renal Fibrosis via TPM1-Mediated Suppression of the Wnt/β-Catenin Pathway. Front Physiol 2020;11:331. [PMID: 32346368 DOI: 10.3389/fphys.2020.00331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
397 Deng Z, He Y, Yang X, Shi H, Shi A, Lu L, He L. MicroRNA-29: A Crucial Player in Fibrotic Disease. Mol Diagn Ther 2017;21:285-94. [PMID: 28130757 DOI: 10.1007/s40291-016-0253-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 13.3] [Reference Citation Analysis]
398 Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y, Wang X, Xu M, Luo G, Zhu Y, Xu Q, Wang X, Kong W. Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification. Arterioscler Thromb Vasc Biol 2012;32:2580-8. [DOI: 10.1161/atvbaha.112.300206] [Cited by in Crossref: 84] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]
399 Palmini G, Marini F, Brandi ML. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma? Molecules 2017;22:E417. [PMID: 28272374 DOI: 10.3390/molecules22030417] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
400 Kota J, Hancock J, Kwon J, Korc M. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Lett. 2017;391:38-49. [PMID: 28093284 DOI: 10.1016/j.canlet.2016.12.035] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 20.8] [Reference Citation Analysis]
401 Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 2016;7:10993. [PMID: 27001906 DOI: 10.1038/ncomms10993] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 24.0] [Reference Citation Analysis]
402 Badal SS, Danesh FR. Managing microvascular complications of diabetes with microRNAs. J Am Soc Nephrol 2012;23:185-7. [PMID: 22241893 DOI: 10.1681/ASN.2011121222] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Huleihel L, Scarritt ME, Badylak SF. The Influence of Extracellular RNA on Cell Behavior in Health, Disease and Regeneration. Curr Pathobiol Rep 2017;5:13-22. [PMID: 28944104 DOI: 10.1007/s40139-017-0121-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Jung YK, Yim HJ. Reversal of liver cirrhosis: current evidence and expectations. Korean J Intern Med. 2017;32:213-228. [PMID: 28171717 DOI: 10.3904/kjim.2016.268] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
405 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
406 Zhang Y, Wu L, Wang Y, Zhang M, Li L, Zhu D, Li X, Gu H, Zhang CY, Zen K. Protective role of estrogen-induced miRNA -29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem. 2012;287:14851-14862. [PMID: 22393047 DOI: 10.1074/jbc.m111.314922] [Cited by in Crossref: 73] [Cited by in F6Publishing: 44] [Article Influence: 8.1] [Reference Citation Analysis]
407 Jafarinejad-Farsangi S, Farazmand A, Mahmoudi M, Gharibdoost F, Karimizadeh E, Noorbakhsh F, Faridani H, Jamshidi AR. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 2015;48:369-78. [PMID: 25857445 DOI: 10.3109/08916934.2015.1030616] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
408 Hsu SH, Ghoshal K. MicroRNAs in Liver Health and Disease. Curr Pathobiol Rep 2013;1:53-62. [PMID: 23565350 DOI: 10.1007/s40139-012-0005-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
409 Gradilone SA, O'Hara SP, Masyuk TV, Pisarello MJ, LaRusso NF. MicroRNAs and benign biliary tract diseases. Semin Liver Dis 2015;35:26-35. [PMID: 25632932 DOI: 10.1055/s-0034-1397346] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
410 Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A, Yamashita S. miR-196a Downregulation Increases the Expression of Type I and III Collagens in Keloid Fibroblasts. Journal of Investigative Dermatology 2012;132:1597-604. [DOI: 10.1038/jid.2012.22] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 10.6] [Reference Citation Analysis]
411 Qiang W, Liu Z, Serna VA, Druschitz SA, Liu Y, Espona-Fiedler M, Wei JJ, Kurita T. Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma. Endocrinology 2014;155:663-9. [PMID: 24424054 DOI: 10.1210/en.2013-1763] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
412 Endo S, Yano A, Fukami T, Nakajima M, Yokoi T. Involvement of miRNAs in the early phase of halothane-induced liver injury. Toxicology 2014;319:75-84. [PMID: 24598351 DOI: 10.1016/j.tox.2014.02.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
413 Zhao D, Long XD, Xia Q. Recent Advances in Etiology of Biliary Atresia. Clin Pediatr (Phila) 2015;54:723-31. [PMID: 25187275 DOI: 10.1177/0009922814548841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
414 Khedr LH, Rahmo RM, Farag DB, Schaalan MF, El Magdoub HM. Crocin attenuates cisplatin-induced hepatotoxicity via TLR4/NF-κBp50 signaling and BAMBI modulation of TGF-β activity: Involvement of miRNA-9 and miRNA-29. Food Chem Toxicol 2020;140:111307. [PMID: 32259551 DOI: 10.1016/j.fct.2020.111307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
415 El-Guendy NM, Helwa R, El-Halawany MS, Abdel Rahman Ali S, Tantawy Aly M, Hasan Alieldin N, Fouad SA, Saeid H, Abdel-Wahab AH. The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study. Hepat Mon 2016;16:e33881. [PMID: 27275163 DOI: 10.5812/hepatmon.33881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
416 Motawi TMK, Sadik NAH, Shaker OG, Ghaleb MH. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Tumor Biol 2016;37:9865-74. [DOI: 10.1007/s13277-016-4884-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
417 Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011;22:1462-74. [PMID: 21784902 DOI: 10.1681/ASN.2010121308] [Cited by in Crossref: 401] [Cited by in F6Publishing: 225] [Article Influence: 40.1] [Reference Citation Analysis]
418 Ohzawa H, Saito A, Kumagai Y, Kimura Y, Yamaguchi H, Hosoya Y, Lefor AK, Sata N, Kitayama J. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement. Oncol Rep 2020;43:1081-8. [PMID: 32323853 DOI: 10.3892/or.2020.7505] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
419 Li C, Bai Y, Liu H, Zuo X, Yao H, Xu Y, Cao M. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim Biophys Sin (Shanghai) 2013;45:692-9. [PMID: 23709205 DOI: 10.1093/abbs/gmt057] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
420 Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol. 2012;590:447-458. [PMID: 22124143 DOI: 10.1113/jphysiol.2011.219691] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 23.8] [Reference Citation Analysis]
421 Hartmann P, Tacke F. Tiny RNA with great effects: miR-155 in alcoholic liver disease. J Hepatol 2016;64:1214-6. [PMID: 26948494 DOI: 10.1016/j.jhep.2016.02.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
422 Huang S, Liu M, Fu F, Liu H, He B, Xiao D, Yang J. High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer. Front Pharmacol 2020;11:572444. [PMID: 33584258 DOI: 10.3389/fphar.2020.572444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Bian EB, Zhao B, Huang C, Wang H, Meng XM, Wu BM, Ma TT, Zhang L, Lv XW, Li J. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery. Cell Signal. 2013;25:1837-1844. [PMID: 23707524 DOI: 10.1016/j.cellsig.2013.05.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
424 Lin F, Wu X, Zhang H, You X, Zhang Z, Shao R, Huang C. A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis. BMC Nephrol 2015;16:48. [PMID: 25884636 DOI: 10.1186/s12882-015-0039-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
425 Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU, McManus DP. Serum Exosomal miRNAs for Grading Hepatic Fibrosis Due to Schistosomiasis. Int J Mol Sci 2020;21:E3560. [PMID: 32443549 DOI: 10.3390/ijms21103560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
426 Hamada-Tsutsumi S, Onishi M, Matsuura K, Isogawa M, Kawashima K, Sato Y, Tanaka Y. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture. Int J Mol Sci 2020;21:E7251. [PMID: 33019495 DOI: 10.3390/ijms21197251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Men R, Wen M, Zhao M, Dan X, Yang Z, Wu W, Wang MH, Liu X, Yang L. MircoRNA-145 promotes activation of hepatic stellate cells via targeting krüppel-like factor 4. Sci Rep 2017;7:40468. [PMID: 28091538 DOI: 10.1038/srep40468] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
428 Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU, McManus DP. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis. EBioMedicine 2018;37:334-43. [PMID: 30482723 DOI: 10.1016/j.ebiom.2018.10.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
429 Lakshman R, Shah R, Reyes-gordillo K, Varatharajalu R. Synergy between NAFLD and AFLD and potential biomarkers. Clinics and Research in Hepatology and Gastroenterology 2015;39:S29-34. [DOI: 10.1016/j.clinre.2015.05.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
430 Shields MA, Dangi-Garimella S, Redig AJ, Munshi HG. Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochem J. 2012;441:541-552. [PMID: 22187935 DOI: 10.1042/bj20111240] [Cited by in Crossref: 128] [Cited by in F6Publishing: 89] [Article Influence: 14.2] [Reference Citation Analysis]
431 Lakner AM, Steuerwald NM, Schrum LW. [Not Available]. Hepatology 2013;57:1286-7. [PMID: 22886552 DOI: 10.1002/hep.25997] [Reference Citation Analysis]
432 Pottier N, Cauffiez C, Perrais M, Barbry P, Mari B. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. Trends Pharmacol Sci 2014;35:119-26. [PMID: 24560301 DOI: 10.1016/j.tips.2014.01.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
433 Hung YH, Kanke M, Kurtz CL, Cubitt RL, Bunaciu RP, Zhou L, White PJ, Vickers KC, Hussain MM, Li X, Sethupathy P. MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner. Front Physiol 2019;10:1367. [PMID: 31736786 DOI: 10.3389/fphys.2019.01367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
434 Fabregat I, Moreno-càceres J, Sánchez A, Dooley S, Dewidar B, Giannelli G, ten Dijke P; the IT-LIVER Consortium. TGF-β signalling and liver disease. FEBS J 2016;283:2219-32. [DOI: 10.1111/febs.13665] [Cited by in Crossref: 247] [Cited by in F6Publishing: 243] [Article Influence: 49.4] [Reference Citation Analysis]
435 O'Reilly S. MicroRNAs in fibrosis: opportunities and challenges. Arthritis Res Ther. 2016;18:11. [PMID: 26762516 DOI: 10.1186/s13075-016-0929-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 18.2] [Reference Citation Analysis]
436 Wang Q, Wang H, Jing Q, Yang Y, Xue D, Hao C, Zhang W. Regulation of Pancreatic Fibrosis by Acinar Cell-Derived Exosomal miR-130a-3p via Targeting of Stellate Cell PPAR-γ. J Inflamm Res 2021;14:461-77. [PMID: 33658824 DOI: 10.2147/JIR.S299298] [Reference Citation Analysis]
437 Ren S, Chen J, Wang Q, Li X, Xu Y, Zhang X, Mu Y, Zhang H, Huang S, Liu P. MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis. Hepatol Int 2019;13:814-25. [PMID: 31643031 DOI: 10.1007/s12072-019-09993-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
438 Liang J, Liu C, Qiao A, Cui Y, Zhang H, Cui A, Zhang S, Yang Y, Xiao X, Chen Y, Fang F, Chang Y. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. Journal of Hepatology 2013;58:535-42. [DOI: 10.1016/j.jhep.2012.10.024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
439 Bagnato G, Roberts WN, Roman J, Gangemi S. A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis. Eur Respir Rev 2017;26:160125. [PMID: 28515040 DOI: 10.1183/16000617.0125-2016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
440 Yuan Y, Li N, Zeng L, Shen Z, Jiang C. Pathogenesis investigation of miR-199-5p in oral submucous fibrosis based on bioinformatics analysis. Oral Dis 2019;25:456-65. [PMID: 30485610 DOI: 10.1111/odi.13008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
441 Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One. 2011;6:e16081. [PMID: 21283674 DOI: 10.1371/journal.pone.0016081] [Cited by in Crossref: 203] [Cited by in F6Publishing: 202] [Article Influence: 20.3] [Reference Citation Analysis]
442 Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, Shen ZY, Cao H, Lu YY, Fang JY. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 2011;6:e25872. [PMID: 21998710 DOI: 10.1371/journal.pone.0025872] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
443 Kanmani P, Suganya K, Kim H. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases.Biomedicines. 2020;8:501. [PMID: 33207562 DOI: 10.3390/biomedicines8110501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
444 Motiño O, Francés DE, Mayoral R, Castro-Sánchez L, Fernández-Velasco M, Boscá L, García-Monzón C, Brea R, Casado M, Agra N, Martín-Sanz P. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling. Mol Cell Biol 2015;35:2554-67. [PMID: 25963660 DOI: 10.1128/MCB.00198-15] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
445 Ramahi A, Altorok N, Kahaleh B. Epigenetics and systemic sclerosis: An answer to disease onset and evolution? Eur J Rheumatol 2020;7:S147-56. [PMID: 32697935 DOI: 10.5152/eurjrheum.2020.19112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
446 Tian S, Chen M, Wang B, Han Y, Shang H, Chen J. miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4. Gastroenterol Res Pract 2020;2020:5346573. [PMID: 32587612 DOI: 10.1155/2020/5346573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
447 Ji X, Wu B, Fan J, Han R, Luo C, Wang T, Yang J, Han L, Zhu B, Wei D, Chen J, Ni C. The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis. Sci Rep 2015;5:14131. [PMID: 26370615 DOI: 10.1038/srep14131] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 9.7] [Reference Citation Analysis]
448 Marchetti A, Bisceglia F, Cozzolino AM, Tripodi M. New Tools for Molecular Therapy of Hepatocellular Carcinoma. Diseases 2015;3:325-40. [PMID: 28943628 DOI: 10.3390/diseases3040325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
449 Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T. Serum Levels of miR-143 Predict Survival in Critically Ill Patients. Dis Markers 2019;2019:4850472. [PMID: 31772686 DOI: 10.1155/2019/4850472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
450 Kwon JJ, Factora TD, Dey S, Kota J. A Systematic Review of miR-29 in Cancer. Mol Ther Oncolytics 2019;12:173-94. [PMID: 30788428 DOI: 10.1016/j.omto.2018.12.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 21.7] [Reference Citation Analysis]
451 Schuppan D, Pinzani M. Anti-fibrotic therapy: lost in translation? J Hepatol 2012;56 Suppl 1:S66-74. [PMID: 22300467 DOI: 10.1016/S0168-8278(12)60008-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 36] [Article Influence: 8.1] [Reference Citation Analysis]
452 Huang YH, Yang YL, Wang FS. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. Int J Mol Sci 2018;19:E1889. [PMID: 29954104 DOI: 10.3390/ijms19071889] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
453 Yan MD, Yao CJ, Chow JM, Chang CL, Hwang PA, Chuang SE, Whang-Peng J, Lai GM. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. Mar Drugs 2015;13:6099-116. [PMID: 26404322 DOI: 10.3390/md13106099] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
454 Wang B, Ricardo S. Role of microRNA machinery in kidney fibrosis. Clin Exp Pharmacol Physiol 2014;41:543-50. [PMID: 24798583 DOI: 10.1111/1440-1681.12249] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
455 Wang M, Li J, Zheng Y. The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review. Med Sci Monit 2020;26:e921514. [PMID: 31949124 DOI: 10.12659/MSM.921514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
456 Sethupathy P. The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases. Curr Diab Rep 2016;16:52. [PMID: 27112956 DOI: 10.1007/s11892-016-0745-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
457 Yano H, Hamanaka R, Nakamura-Ota M, Zhang JJ, Matsuo N, Yoshioka H. Regulation of type I collagen expression by microRNA-29 following ionizing radiation. Radiat Environ Biophys 2018;57:41-54. [PMID: 29230533 DOI: 10.1007/s00411-017-0723-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
458 Bian EB, Li J, Zhao B. miR-29, a potential therapeutic target for liver fibrosis. Gene 2014;544:259-60. [PMID: 24792894 DOI: 10.1016/j.gene.2014.04.076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
459 Yu P, Yan M, Lai H, Huang R, Chou Y, Lin W, Yeh L, Lin Y. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells: miR-29 Regulates Cisplatin Sensitivity of Ovarian Cancer. Int J Cancer 2014;134:542-51. [DOI: 10.1002/ijc.28399] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 9.8] [Reference Citation Analysis]
460 Palanichamy JK, Rao DS. miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet. 2014;5:54. [PMID: 24672539 DOI: 10.3389/fgene.2014.00054] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
461 Abu-Halima M, Meese E, Saleh MA, Keller A, Abdul-Khaliq H, Raedle-Hurst T. MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation. Front Cardiovasc Med 2020;7:619083. [PMID: 33490119 DOI: 10.3389/fcvm.2020.619083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
462 Guo W, Benlhabib H, Mendelson CR. The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung. Mol Cell Biol 2016;36:2141. [PMID: 27215389 DOI: 10.1128/MCB.00096-16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
463 Panizo S, Carrillo-López N, Naves-Díaz M, Solache-Berrocal G, Martínez-Arias L, Rodrigues-Díez RR, Fernández-Vázquez A, Martínez-Salgado C, Ruiz-Ortega M, Dusso A, Cannata-Andía JB, Rodríguez I. Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis. Nephrol Dial Transplant 2017;32:1831-40. [PMID: 28460073 DOI: 10.1093/ndt/gfx060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
464 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg.2011.02.005] [Cited by in Crossref: 525] [Cited by in F6Publishing: 517] [Article Influence: 52.5] [Reference Citation Analysis]
465 Chen SL, Zheng MH, Shi KQ, Yang T, Chen YP. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs. 2013;27:25-34. [PMID: 23329398 DOI: 10.1007/s40259-012-0005-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
466 Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. J Pathol. 2014;234:46-59. [PMID: 24817606 DOI: 10.1002/path.4373] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 12.6] [Reference Citation Analysis]
467 Herter EK, Xu Landén N. Non-Coding RNAs: New Players in Skin Wound Healing. Adv Wound Care (New Rochelle) 2017;6:93-107. [PMID: 28289554 DOI: 10.1089/wound.2016.0711] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
468 Wu G, Xie B, Lu C, Chen C, Zhou J, Deng Z. microRNA-30a attenuates TGF-β1-induced activation of pulmonary fibroblast cell by targeting FAP-α. J Cell Mol Med 2020;24:3745-50. [PMID: 31991519 DOI: 10.1111/jcmm.15020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
469 Moraes LN, Fernandez GJ, Vechetti-Júnior IJ, Freire PP, Souza RWA, Villacis RAR, Rogatto SR, Reis PP, Dal-Pai-Silva M, Carvalho RF. Integration of miRNA and mRNA expression profiles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia. Sci Rep 2017;7:6998. [PMID: 28765595 DOI: 10.1038/s41598-017-07236-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
470 Cushing L, Kuang P, Lü J. The role of miR-29 in pulmonary fibrosis. Biochem Cell Biol 2015;93:109-18. [PMID: 25454218 DOI: 10.1139/bcb-2014-0095] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 8.7] [Reference Citation Analysis]
471 Lopez-Anton M, Bowen T, Jenkins RH. microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis. Biomed Res Int 2015;2015:929806. [PMID: 26495316 DOI: 10.1155/2015/929806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
472 Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, Vucur M, Gautheron J, Schneider AT, Koppe C, Kreggenwinkel K, Zimmermann HW, Luedde M, Trautwein C, Tacke F, Luedde T. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int. 2015;35:1172-1184. [PMID: 25039534 DOI: 10.1111/liv.12627] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 11.1] [Reference Citation Analysis]
473 John K, Hadem J, Krech T, Wahl K, Manns MP, Dooley S, Batkai S, Thum T, Schulze-Osthoff K, Bantel H. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 2014;60:1346-1355. [PMID: 24913549 DOI: 10.1002/hep.27250] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
474 Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011;412:74-79. [PMID: 21798245 DOI: 10.1016/j.bbrc.2011.07.041] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 11.9] [Reference Citation Analysis]
475 Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res 2012;110:312-24. [PMID: 22116819 DOI: 10.1161/CIRCRESAHA.111.253740] [Cited by in Crossref: 126] [Cited by in F6Publishing: 82] [Article Influence: 12.6] [Reference Citation Analysis]
476 Uschner FE, Schueller F, Nikolova I, Klein S, Schierwagen R, Magdaleno F, Gröschl S, Loosen S, Ritz T, Roderburg C, Vucur M, Kristiansen G, Lammers T, Luedde T, Trebicka J. The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension. Oncotarget 2018;9:36220-37. [PMID: 30546838 DOI: 10.18632/oncotarget.26333] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
477 Xiao L, Wang JY. RNA-binding proteins and microRNAs in gastrointestinal epithelial homeostasis and diseases. Curr Opin Pharmacol 2014;19:46-53. [PMID: 25063919 DOI: 10.1016/j.coph.2014.07.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
478 Nishikawa R, Chiyomaru T, Enokida H, Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa M, Seki N. Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma. FEBS Lett 2015;589:2136-45. [PMID: 26096783 DOI: 10.1016/j.febslet.2015.06.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
479 Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis. 2013;45:543-551. [PMID: 23280158 DOI: 10.1016/j.dld.2012.11.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
480 Bandopadhyay M, Bharadwaj M. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020;12:23. [PMID: 32346400 DOI: 10.1186/s13099-020-00353-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
481 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 343] [Article Influence: 49.6] [Reference Citation Analysis]
482 Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang Z, Hu K, Dong P, Han X. The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep 2017;7:40958. [PMID: 28098218 DOI: 10.1038/srep40958] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
483 Zheng J, Mao Y, Dong P, Huang Z, Yu F. Long noncoding RNA HOTTIP mediates SRF expression through sponging miR-150 in hepatic stellate cells. J Cell Mol Med 2019;23:1572-80. [PMID: 30548190 DOI: 10.1111/jcmm.14068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
484 Kriegel AJ, Mladinov D, Liang M. Translational study of microRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond) 2012;122:439-47. [PMID: 22283365 DOI: 10.1042/CS20110159] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
485 Luedde T, Schwabe RF. NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011;8:108-18. [PMID: 21293511 DOI: 10.1038/nrgastro.2010.213] [Cited by in Crossref: 673] [Cited by in F6Publishing: 660] [Article Influence: 67.3] [Reference Citation Analysis]
486 Geisler L, Mohr R, Lambrecht J, Knorr J, Jann H, Loosen SH, Özdirik B, Luedde T, Hammerich L, Tacke F, Wree A, Hellberg T, Roderburg C. The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors. Int J Mol Sci 2021;22:8569. [PMID: 34445276 DOI: 10.3390/ijms22168569] [Reference Citation Analysis]
487 Nakamura K, Tanoue A. Etiology of biliary atresia as a developmental anomaly: recent advances. J Hepatobiliary Pancreat Sci 2013;20:459-64. [PMID: 23567964 DOI: 10.1007/s00534-013-0604-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
488 Lewis A, Mehta S, Hanna LN, Rogalski LA, Jeffery R, Nijhuis A, Kumagai T, Biancheri P, Bundy JG, Bishop CL, Feakins R, Di Sabatino A, Lee JC, Lindsay JO, Silver A. Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype. Inflamm Bowel Dis. 2015;21:1926-1934. [PMID: 25985247 DOI: 10.1097/mib.0000000000000443] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
489 Li J, Zhang Y, Kuruba R, Gao X, Gandhi CR, Xie W, Li S. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol. 2011;80:191-200. [PMID: 21511916 DOI: 10.1124/mol.110.068247] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
490 Han X, Hao C, Li L, Li J, Fang M, Zheng Y, Lu J, Li P, Xu Y. HDAC4 stimulates MRTF-A expression and drives fibrogenesis in hepatic stellate cells by targeting miR-206. Oncotarget 2017;8:47586-94. [PMID: 28548935 DOI: 10.18632/oncotarget.17739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
491 Liu S, Huang X, Liu Y, Song D, Xiao Y. Functional analysis of miRNAs combined with TGF-β1/Smad3 inhibitor in an intrauterine rat adhesion cell model. Mol Cell Biochem 2020;470:15-28. [PMID: 32447720 DOI: 10.1007/s11010-020-03741-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
492 Roy S, Benz F, Alder J, Bantel H, Janssen J, Vucur M, Gautheron J, Schneider A, Schüller F, Loosen S, Luedde M, Koch A, Tacke F, Luedde T, Trautwein C, Roderburg C. Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury. Clinical Science 2016;130:1197-207. [DOI: 10.1042/cs20160216] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
493 Nan Y, Niu X, Wang R, Zhao S, Fu N, Du J, Wang Y, Wang B, Zhang Y. microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. Exp Ther Med 2019;17:1817-24. [PMID: 30783454 DOI: 10.3892/etm.2018.7114] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
494 Pant K, Venugopal SK. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clinics and Research in Hepatology and Gastroenterology 2017;41:370-7. [DOI: 10.1016/j.clinre.2016.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
495 Vukmirovic M, Kaminski N. Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis. Front Med (Lausanne) 2018;5:87. [PMID: 29670881 DOI: 10.3389/fmed.2018.00087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
496 Chen L, Ji X, Wang M, Liao X, Liang C, Tang J, Wen Z, Dominique F, Li Z. Involvement of TLR4 signaling regulated-COX2/PGE2 axis in liver fibrosis induced by Schistosoma japonicum infection. Parasit Vectors 2021;14:279. [PMID: 34034779 DOI: 10.1186/s13071-021-04790-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
497 李曼蓉, 陆伦根, 卜平. 肝纤维化中表观遗传学调控的研究进展. 世界华人消化杂志 2013; 21(32): 3499-3504 [DOI: 10.11569/wcjd.v21.i32.3499] [Reference Citation Analysis]
498 Hyun J, Park J, Wang S, Kim J, Lee HH, Seo YS, Jung Y. MicroRNA Expression Profiling in CCl4-Induced Liver Fibrosis of Mus musculus. Int J Mol Sci. 2016;17:pii E961. [PMID: 27322257 DOI: 10.3390/ijms17060961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
499 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11.011] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 13.2] [Reference Citation Analysis]
500 Han X, Hong Y, Zhang K. TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b. Biochem Biophys Res Commun 2018;503:1394-400. [PMID: 30017186 DOI: 10.1016/j.bbrc.2018.07.054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
501 Hoffmann TW, Duverlie G, Bengrine A. MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy. Virol J 2012;9:109. [PMID: 22691570 DOI: 10.1186/1743-422X-9-109] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
502 Lv C, Ding W, Wang Y, Zhao Z, Li J, Chen Y, Lv J. A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis. Int Urol Nephrol 2018;50:973-82. [DOI: 10.1007/s11255-017-1779-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
503 Loosen SH, Wirtz TH, Roy S, Vucur M, Castoldi M, Schneider AT, Koppe C, Ulmer TF, Roeth AA, Bednarsch J, Alizai PH, Paffenholz P, Demir M, Trautwein C, Tacke F, Neumann UP, Roderburg C, Luedde T. Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma. PLoS One 2020;15:e0239386. [PMID: 32960907 DOI: 10.1371/journal.pone.0239386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
504 Hyun J, Choi SS, Diehl AM, Jung Y. Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKβ-deficient mouse. J Mol Hist 2014;45:103-12. [DOI: 10.1007/s10735-013-9532-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
505 Atta HM. Reversibility and heritability of liver fibrosis: Implications for research and therapy. World J Gastroenterol 2015; 21(17): 5138-5148 [PMID: 25954087 DOI: 10.3748/wjg.v21.i17.5138] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
506 Li Q, Li Z, Lin Y, Che H, Hu Y, Kang X, Zhang Y, Wang L, Zhang Y. High glucose promotes hepatic fibrosis via miR‑32/MTA3‑mediated epithelial‑to‑mesenchymal transition. Mol Med Rep 2019;19:3190-200. [PMID: 30816482 DOI: 10.3892/mmr.2019.9986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
507 Thompson KJ, McKillop IH, Schrum LW. Targeting collagen expression in alcoholic liver disease. World J Gastroenterol 2011; 17(20): 2473-2481 [PMID: 21633652 DOI: 10.3748/wjg.v17.i20.2473] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
508 Rana I, Kompa AR, Skommer J, Wang BH, Lekawanvijit S, Kelly DJ, Krum H, Charchar FJ. Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins. Physiol Rep 2015;3:e12371. [PMID: 25896982 DOI: 10.14814/phy2.12371] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
509 Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, Jia JH. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun. 2011;411:586-592. [PMID: 21763284 DOI: 10.1016/j.bbrc.2011.06.191] [Cited by in Crossref: 93] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
510 Guo L, Li W, Hu L, Zhou H, Zheng L, Yu L, Liang W. Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis. Oncotarget. 2018;9:5397-5405. [PMID: 29435187 DOI: 10.18632/oncotarget.23332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
511 March JT, Golshirazi G, Cernisova V, Carr H, Leong Y, Lu-Nguyen N, Popplewell LJ. Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides. Biomedicines 2018;6:E74. [PMID: 29941814 DOI: 10.3390/biomedicines6030074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
512 Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M, Boyer N, Vidaud M, Bedossa P, Marcellin P, Bièche I, Estrabaud E, Asselah T. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep 2016;6:34935. [PMID: 27731343 DOI: 10.1038/srep34935] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
513 Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ, Paulaitis ME, Brigstock DR. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 2014;59:1118-29. [PMID: 24122827 DOI: 10.1002/hep.26768] [Cited by in Crossref: 159] [Cited by in F6Publishing: 153] [Article Influence: 22.7] [Reference Citation Analysis]
514 Millar NL, Gilchrist DS, Akbar M, Reilly JH, Kerr SC, Campbell AL, Murrell GAC, Liew FY, Kurowska-Stolarska M, McInnes IB. MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun 2015;6:6774. [PMID: 25857925 DOI: 10.1038/ncomms7774] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 16.5] [Reference Citation Analysis]
515 Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60:1063-1074. [PMID: 24412608 DOI: 10.1016/j.jhep.2013.12.026] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 15.6] [Reference Citation Analysis]
516 Marsh EE, Steinberg ML, Parker JB, Wu J, Chakravarti D, Bulun SE. Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production. Fertil Steril 2016;106:766-72. [PMID: 27233758 DOI: 10.1016/j.fertnstert.2016.05.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
517 Shen WJ, Dong R, Chen G, Zheng S. microRNA-222 modulates liver fibrosis in a murine model of biliary atresia. Biochem Biophys Res Commun. 2014;446:155-159. [PMID: 24569080 DOI: 10.1016/j.bbrc.2014.02.065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
518 Zou XZ, Liu T, Gong ZC, Hu CP, Zhang Z. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. Eur J Pharmacol 2017;796:190-206. [PMID: 27916556 DOI: 10.1016/j.ejphar.2016.12.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
519 Zhu Y, Li Z, Wang Y, Li L, Wang D, Zhang W, Liu L, Jiang H, Yang J, Cheng J. Overexpression of miR-29b reduces collagen biosynthesis by inhibiting heat shock protein 47 during skin wound healing. Transl Res 2016;178:38-53.e6. [PMID: 27477081 DOI: 10.1016/j.trsl.2016.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
520 Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 2013;305:C789-99. [PMID: 23903700 DOI: 10.1152/ajpcell.00230.2013] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 18.0] [Reference Citation Analysis]
521 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Reference Citation Analysis]
522 Wang F, Chung P, Lin C, Chen M, Ke H, Chang Y, Chen Y, Wu S, Ko J. MicroRNA-29a Protects Against Glucocorticoid-Induced Bone Loss and Fragility in Rats by Orchestrating Bone Acquisition and Resorption: MicroRNA-29a Ameliorates Bone Loss. Arthritis & Rheumatism 2013;65:1530-40. [DOI: 10.1002/art.37948] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 10.8] [Reference Citation Analysis]
523 Johnston EF, Cadonic IG, Craig PM, Gillis TE. microRNA-29b knocks down collagen type I production in cultured rainbow trout (Oncorhynchus mykiss) cardiac fibroblasts. J Exp Biol 2019;222:jeb202788. [PMID: 31439649 DOI: 10.1242/jeb.202788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
524 Huang Y, Fan X, Tao R, Song Q, Wang L, Zhang H, Kong H, Huang J. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway. J Cell Physiol 2018;233:6693-704. [PMID: 29323718 DOI: 10.1002/jcp.26469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
525 Lin H, Ewing LE, Koturbash I, Gurley BJ, Miousse IR. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food Chem Toxicol 2017;110:229-39. [PMID: 29042291 DOI: 10.1016/j.fct.2017.10.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
526 Gupta P, Liu B, Wu JQ, Soriano V, Vispo E, Carroll AP, Goldie BJ, Cairns MJ, Saksena NK. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection. Virology. 2014;450-451:336-349. [PMID: 24503097 DOI: 10.1016/j.virol.2013.12.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
527 Shen W, Chen G, Dong R, Zhao R, Zheng S. MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia. Journal of Pediatric Surgery 2014;49:1738-41. [DOI: 10.1016/j.jpedsurg.2014.09.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
528 Jiang L, Zhou Y, Xiong M, Fang L, Wen P, Cao H, Yang J, Dai C, He W. Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells. Exp Cell Res 2013;319:2254-65. [PMID: 23806282 DOI: 10.1016/j.yexcr.2013.06.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
529 O'Reilly S. Epigenetics in fibrosis. Mol Aspects Med 2017;54:89-102. [PMID: 27720780 DOI: 10.1016/j.mam.2016.10.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
530 Yang Z, Wang L. Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 2011;1:31. [PMID: 21936947 DOI: 10.1186/2045-3701-1-31] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
531 Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
532 Thirion M, Ochiya T. Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses. 2013;5:2690-2703. [PMID: 24212236 DOI: 10.3390/v5112690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
533 Pisarello MJ, Loarca L, Ivanics T, Morton L, LaRusso N. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. J Clin Med 2015;4:1688-712. [PMID: 26343736 DOI: 10.3390/jcm4091688] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
534 Wilson CL, Mann DA, Borthwick LA. Epigenetic reprogramming in liver fibrosis and cancer. Adv Drug Deliv Rev. 2017;121:124-132. [PMID: 29079534 DOI: 10.1016/j.addr.2017.10.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
535 Ślusarz A, Pulakat L. The two faces of miR-29. J Cardiovasc Med (Hagerstown) 2015;16:480-90. [PMID: 25689084 DOI: 10.2459/JCM.0000000000000246] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 9.4] [Reference Citation Analysis]
536 Kang N, Shah VH, Urrutia R. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res 2015;13:604-12. [PMID: 25548101 DOI: 10.1158/1541-7786.MCR-14-0542] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
537 Zhao Y, Dang Z, Chong S. Mmu-miR-92a-2-5p targets TLR2 to relieve Schistosoma japonicum-induced liver fibrosis. Int Immunopharmacol 2019;69:126-35. [PMID: 30708193 DOI: 10.1016/j.intimp.2019.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
538 Wei J, Feng L, Li Z, Xu G, Fan X. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed Pharmacother. 2013;67:387-392. [PMID: 23643356 DOI: 10.1016/j.biopha.2013.03.014] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 9.5] [Reference Citation Analysis]
539 Zeng C, Wang YL, Xie C, Sang Y, Li TJ, Zhang M, Wang R, Zhang Q, Zheng L, Zhuang SM. Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Oncotarget 2015;6:12224-33. [PMID: 25909171 DOI: 10.18632/oncotarget.3652] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
540 Fu Q, Shi H, Ni W, Shi M, Meng L, Zhang H, Ren Y, Guo F, Wang P, Qiao J, Jia B, Chen C. Lentivirus-mediated Bos taurus bta-miR-29b overexpression interferes with bovine viral diarrhoea virus replication and viral infection-related autophagy by directly targeting ATG14 and ATG9A in Madin-Darby bovine kidney cells. J Gen Virol 2015;96:85-94. [PMID: 25234643 DOI: 10.1099/vir.0.067140-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
541 Brea R, Motiño O, Francés D, García-Monzón C, Vargas J, Fernández-Velasco M, Boscá L, Casado M, Martín-Sanz P, Agra N. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p. Biochim Biophys Acta Mol Basis Dis 2018;1864:325-37. [PMID: 29109031 DOI: 10.1016/j.bbadis.2017.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
542 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
543 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
544 Lee K, Hardy DB. Metabolic Consequences of Gestational Cannabinoid Exposure. Int J Mol Sci 2021;22:9528. [PMID: 34502436 DOI: 10.3390/ijms22179528] [Reference Citation Analysis]
545 Wang JY, Cui YH, Xiao L, Chung HK, Zhang Y, Rao JN, Gorospe M, Wang JY. Regulation of Intestinal Epithelial Barrier Function by Long Noncoding RNA uc.173 through Interaction with MicroRNA 29b. Mol Cell Biol 2018;38:e00010-18. [PMID: 29632078 DOI: 10.1128/MCB.00010-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
546 Roncarati R, Viviani Anselmi C, Losi MA, Papa L, Cavarretta E, Da Costa Martins P, Contaldi C, Saccani Jotti G, Franzone A, Galastri L. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2014;63:920-927. [PMID: 24161319 DOI: 10.1016/j.jacc.2013.09.041] [Cited by in Crossref: 178] [Cited by in F6Publishing: 172] [Article Influence: 22.3] [Reference Citation Analysis]
547 Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 17.3] [Reference Citation Analysis]
548 Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM. miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns. Mol Med Rep 2018;17:7105-12. [PMID: 29568927 DOI: 10.3892/mmr.2018.8778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
549 Huang Y, Zhang C, Wang Y, Sun X. Identification and analysis of miRNAs in the normal and fatty liver from the Holstein dairy cow. Anim Biotechnol 2020;:1-12. [PMID: 32838638 DOI: 10.1080/10495398.2020.1804919] [Reference Citation Analysis]
550 Duong TE, Hagood JS. Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis. Curr Pathobiol Rep 2018;6:79-96. [PMID: 30271681 DOI: 10.1007/s40139-018-0155-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
551 Zimmer V, Lammert F. Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:269-280. [PMID: 21497744 DOI: 10.1016/j.bpg.2011.02.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
552 Kamikawaji K, Seki N, Watanabe M, Mataki H, Kumamoto T, Takagi K, Mizuno K, Inoue H. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. J Hum Genet 2016;61:985-93. [PMID: 27488440 DOI: 10.1038/jhg.2016.99] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
553 Saikumar J, Ramachandran K, Vaidya VS. Noninvasive micromarkers. Clin Chem. 2014;60:1158-1173. [PMID: 24407912 DOI: 10.1373/clinchem.2013.216044] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
554 Yang YL, Kuo HC, Wang FS, Huang YH. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. Int J Mol Sci 2019;20:E1499. [PMID: 30917489 DOI: 10.3390/ijms20061499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]